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CHAPTER 1 -  INTRODUCTION 
Cardiovascular responses during dynamic exercise are a result of a complex 
interaction between at least three mechanisms: central command, the arterial baroreflex 
and the muscle metaboreflex.  Central command primarily controls parasympathetic 
activity to the heart and has little control over sympathetic nerve activity (SNA) (89).  
The arterial baroreflex is a negative feedback reflex which maintains arterial pressure 
primarily by modulating peripheral vascular conductance.  An increase in arterial 
pressure causes baroreflex-induced peripheral vasodilation and bradycardia while a 
decrease in arterial pressure evokes peripheral vasoconstriction and tachycardia, 
restoring arterial pressure back to normal in both scenarios.  During exercise, the 
arterial baroreflex is reset to a higher level but without any change in the gain of reflex 
(20, 53, 62).  The muscle metaboreflex is activated when insufficient oxygen delivery to 
the exercising skeletal muscle results in accumulation of metabolites (e.g., hydrogen 
ions, adenosine, diprotonated phosphate, etc.) which stimulate the group III/IV muscle 
afferents eliciting a large pressor response, termed the muscle metaboreflex (1, 9, 65, 
76, 77).  
Muscle metaboreflex activation (MMA) during dynamic exercise causes 
significant increases in mean arterial pressure (MAP), heart rate (HR), cardiac output 
(CO) and ventricular contractility which along with enhanced central blood volume 
mobilization maintains or slightly increases stroke volume (6, 18, 43, 70, 71, 95).  With 
stroke volume being maintained, the rise in HR elicits substantial increases in CO.  
However, the peripheral vascular responses have varied in previous studies.  While 
significant vasoconstriction has been observed in the renal, coronary and forelimb 
vascular beds (6, 13, 48, 49) when taken as a whole, the total vascular conductance of 
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all vascular beds except the hindlimbs, termed non-ischemic vascular conductance 
(NIVC), usually remains unchanged or slightly increases (6, 13, 40, 69, 78).  Inasmuch 
as some individual vascular beds do vasoconstrict, the observation of no change or 
slight increase in NIVC indicates that some vascular bed(s) must vasodilate.  What 
causes this vasodilation is unknown.  Metaboreflex-mediated increases in SNA can lead 
to elevated pre-ganglionic sympathetic activity to the adrenal glands which can 
substantially increase epinephrine release (8, 41, 44, 46) resulting in β2-mediated 
vasodilation, especially in the skeletal muscle which is richly endowed with β2-
adrenergic receptors.  In addition, post-ganglionic sympathetic nerve terminals have 
also been shown to release epinephrine (8, 41, 44, 46).  However, whether epinephrine 
release contributes to muscle metaboreflex-induced peripheral vascular responses is 
unknown. 
Muscle metaboreflex is generally considered as a flow-mediated, flow-raising 
reflex which is activated by insufficient blood flow and oxygen delivery to the active 
skeletal muscle and raises total systemic blood flow (i.e., CO) to improve blood flow and 
oxygen delivery to the ischemic vasculature.  MMA during submaximal exercise 
increases MAP, HR, CO and ventricular contractility along with some regional 
vasoconstriction (6, 13, 48, 49).  The metaboreflex-induced increase in MAP is primarily 
caused by an increase in CO, as little if any net peripheral vasoconstriction occurs (18, 
32, 71, 74).  Several studies have suggested that the metaboreflex-induced increase in 
CO partially restores blood flow to the ischemic active skeletal muscle (16, 56, 59, 68).  
Whether the increased SNA during MMA activation vasoconstricts the ischemic active 
muscle from which the reflex originates is unknown.  Should this occur, then the ability 
of the muscle metaboreflex to correct the deficits in blood flow to the ischemic muscle 
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would be restrained.  
Heart failure (HF) is characterized by low CO and high SNA during rest and 
exercise.  With only moderate exercise, massive sympathetic activation is often 
observed in HF, resulting in an exaggerated metaboreflex activation (29).  With the 
normal metaboreflex-induced increases in CO being substantially attenuated in HF, the 
mechanisms of metaboreflex shift from flow-mediated to vasoconstriction-mediated 
pressor responses in HF (16, 29, 58).  The ability of vasoconstriction in a given vascular 
bed to raise MAP is directly related to the fraction of CO received by that bed.  During 
exercise most of the CO is directed to the active skeletal muscle.  Vasoconstriction of 
inactive vascular beds plays a very small role in any reflex pressor response as blood 
flow to the inactive beds constitutes only a small proportion of CO and thereby, total 
vascular conductance (TVC).  With a large proportion of CO going to the exercising 
skeletal muscle, it is this vascular bed which is the likely target vasculature for 
metaboreflex-induced vasoconstriction in HF.  With exaggerated SNA in HF, 
metaboreflex activation could lead to heightened vasoconstriction of active muscle, 
possibly including the ischemic muscle itself.  In this case, vasoconstriction of the 
already ischemic muscle would lead to further ischemia in the muscle that would 
potentiate the reflex activation causing a positive feedback loop scenario.  Whether 
MMA in HF induces an exaggerated vasoconstriction of ischemic active muscle itself is 
unknown.  
Another key regulator of arterial blood pressure is the arterial baroreflex.  During 
dynamic exercise in normal individuals, arterial baroreflex is reset to a higher arterial 
pressure although its strength to regulate pressure remains unaltered (21, 53, 62, 67).  
Sheriff et. al. (72) showed that during MMA, baroreflex buffers up to 50% of the 
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metaboreflex-mediated increases in MAP.  Kim et. al. (40) demonstrated that this 
buffering occurs by restraining metaboreflex-induced peripheral vasoconstriction.  After 
sinoaortic denervation (SAD) in the same animals, metaboreflex-induced pressor 
response was twice as large and resulted from a combination of peripheral 
vasoconstriction and increase in CO.  Thus, the arterial baroreflex alters the strength 
and mechanisms of the muscle metaboreflex during dynamic exercise by inhibiting 
metaboreflex-mediated peripheral vasoconstriction.  When carotid receptors are 
unloaded via bilateral carotid occlusion (BCO), the substantial increase in MAP occurs 
primarily due to peripheral vasoconstriction (11).  Therefore, muscle metaboreflex and 
arterial baroreflex have distinct mechanisms for regulating MAP and no studies have yet 
investigated the interaction between the two when activated concurrently.  The 
interaction of the arterial baroreflex and the muscle metaboreflex has not been well 
established, especially when these reflexes are coactivated.  Furthermore, previous 
studies from our laboratory have concluded that active skeletal muscle is a primary 
target for baroreflex-induced peripheral vasoconstriction (11). To what extent ischemic 
active muscle may vasoconstrict is controversial. 
HF alters the strength of arterial baroreflex both at rest (61) and during exercise 
(38).  This impairment would lessen the ability of baroreflex to attenuate peripheral 
vasoconstriction induced by muscle metaboreflex, leading to a larger increase in 
vascular sympathetic tone compared to normal subjects.  Inasmuch as the strength of 
the baroreflex and baroreflex buffering of metaboreflex-induced pressor response are 
impaired in HF, there would be a smaller pressor response with metaboreflex and 
baroreflex coactivation.  To what extent HF alters the interaction between the baroreflex 
and muscle metaboreflex is unknown.  Therefore, my studies are designed to address 
5 
 
three tightly coupled Specific Aims.  My approach is to use a complex chronically 
instrumented canine model.  All studies are longitudinal in nature.  The animals are 
instrumented and responses are observed on different days and in different settings 
(e.g. agonist/antagonist infusions, rest vs. exercise, etc.), then heart failure is induced 
and the experiments are repeated in the same animals. Thus, each animal serves as its 
own control. 
Specific Aim (I): To determine the mechanism(s) mediating muscle metaboreflex 
control of blood flow to the non-ischemic active vasculature during dynamic 
exercise.   
Muscle metaboreflex-induced pressor response is caused virtually solely by an 
increase in cardiac output, as little, if any, increase in total vascular conductance 
occurs.  In several studies, we observed that muscle metaboreflex activation caused a 
significant increase in vascular conductance of all vascular beds except the hindlimbs 
(termed non-ischemic vascular conductance; NIVC) (6, 40, 69).  I hypothesized that this 
increase in NIVC may stem from a metaboreflex-induced release of epinephrine 
resulting in β2-adrenergic mediated vasodilation in the skeletal muscle.  
Specific Aim (II): To determine the mechanism(s) mediating muscle metaboreflex 
control of blood flow to the ischemic active vasculature during submaximal 
dynamic exercise in normal animals and in the same animals after induction of 
heart failure.   
We and others have shown that MMA elicits vasoconstriction of the coronary, 
renal and forelimb vasculatures.  Whether the metaboreflex vasoconstricts the ischemic 
muscle from which it originates has been controversial. HF is characterized by markedly 
elevated SNA both at rest and during exercise.  When metaboreflex-induced increase in 
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cardiac output becomes limited in HF, MMA causes large peripheral vasoconstriction.  
Whether MMA in HF causes exaggerated vasoconstriction of the ischemic active 
muscle is unknown.  I hypothesized that MMA elicits vasoconstriction of the active 
skeletal muscle in normal subjects and this vasoconstriction is exacerbated in HF. 
Specific Aim (III): To investigate the interaction between the muscle metaboreflex 
and the arterial baroreflex before and after induction of heart failure.   
Activation of both reflexes would cause an exaggerated pressor response, a 
resultant effect of both, an increase in CO and peripheral vasoconstriction.  I tested 
whether the interaction between the two reflexes is additive, occlusive or facilitative.  
Since carotid baroreceptor unloading induces peripheral vasoconstriction, to what 
extent the ischemic muscle vasoconstricts during coactivation of the baroreflex and the 
muscle metaboreflex is unknown.  The strength of arterial baroreflex is impaired in HF 
and coactivation of metaboreflex and baroreflex in HF would cause a smaller pressor 
response compared to normal individuals.  
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CHAPTER 2 - MUSCLE METABOREFLEX ACTIVATION DURING DYNAMIC 
EXERCISE EVOKES EPINEPHRINE RELEASE RESULTING IN β2-MEDIATED 
VASODILATION 
(This Chapter contains previously published material. See Appendix B) 
Abstract 
Muscle metaboreflex-induced increases in mean arterial pressure (MAP) during 
submaximal dynamic exercise are mediated principally by increases in cardiac output.  
To what extent, if any, the peripheral vasculature contributes to this rise in MAP is 
debatable.  In several studies, we observed that in response to muscle metaboreflex 
activation (MMA; induced by partial hindlimb ischemia) a small but significant increase 
in vascular conductance occurred within the non-ischemic areas (calculated as cardiac 
output minus hindlimb blood flow and termed non-ischemic vascular conductance; 
NIVC).  We hypothesized that these increases in NIVC may stem from a metaboreflex-
induced release of epinephrine resulting in β2-mediated dilation.  We measured NIVC 
and arterial plasma epinephrine levels in chronically instrumented dogs during rest, mild 
exercise (3.2 kph) and MMA before and after β-adrenergic blockade (propranolol; 2 
mg/kg), α1-adrenergic blockade (prazosin; 50 µg/kg) and α1+β-blockade.  Both 
epinephrine and NIVC increased significantly from exercise to MMA: 81.9 ± 18.6 to 
141.3 ± 22.8 pg/ml and 33.8 ± 1.5 to 37.6 ± 1.6 ml/min/mmHg, respectively.  These 
metaboreflex-induced increases in NIVC were abolished after β-blockade (27.6 ± 1.8 to 
27.5 ± 1.7 ml/min/mmHg) and potentiated after α1-blockade (36.6 ± 2.0 to 49.7 ± 2.9 
ml/min/mmHg), while α1+β-blockade also abolished any vasodilation (33.7 ± 2.9 to 30.4 
± 1.9 ml/min/mmHg).  We conclude that MMA during mild dynamic exercise induces 
epinephrine release causing β2-mediated vasodilation. 
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Introduction 
Insufficient oxygen delivery to active skeletal muscle during dynamic exercise 
causes accumulation of metabolites (e.g., hydrogen ions, lactate, diprotonated 
phosphate, etc.) which activate group III/IV chemosensitive afferents eliciting a reflex 
increase in arterial blood pressure and sympathetic outflow, known as the muscle 
metaboreflex (1, 9, 43, 65, 66, 75-77, 95).  The metaboreflex-mediated pressor 
response during submaximal dynamic exercise occurs virtually solely via increases in 
cardiac output (CO) as no net peripheral vasoconstriction occurs (18, 32, 70, 71, 74, 
78).  The rise in CO is supported by substantial tachycardia, improved ventricular 
contractility which along with enhanced central blood volume mobilization facilitates a 
maintained or slightly elevated stroke volume (13, 16-18, 26, 69-71, 74). 
Several studies have suggested that the muscle metaboreflex improves blood 
flow to the ischemic working muscle (16, 56, 59, 68, 95).  However, very few studies 
have investigated the effect of muscle metaboreflex activation on blood flow to non-
ischemic active muscle and the results are equivocal.  Using the model originally 
developed by Wyss et al. (95) to investigate the metaboreflex (graded reductions in 
hindlimb blood flow), Mittelstadt et al. (48) showed that metaboreflex activation during 
moderate exercise in canines causes forelimb (a non-ischemic active tissue) 
vasoconstriction, however forelimb blood flow still increased due to the large pressor 
response (the rise in arterial pressure was greater than the fall in forelimb vascular 
conductance, therefore forelimb blood flow increased).  In contrast, Augustyniak et al. 
(5) did not find a significant decrease in forelimb conductance with metaboreflex 
activation during moderate exercise. 
In previous studies in normal animals, we often observed a small but statistically 
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significant metaboreflex-mediated increase in the total non-ischemic systemic vascular 
conductance (NIVC) (conductance to all vascular beds excluding the hindlimbs) during 
submaximal dynamic exercise (6, 40, 69).  In contrast, after induction of heart failure 
this small vasodilation is reversed to a substantial metaboreflex-mediated peripheral 
vasoconstriction due to much greater reflex increase in sympathetic activity (29).  
Therefore there appears to be both vasodilator as well as vasoconstrictor processes 
elicited by metaboreflex activation.  Whereas many studies have shown that activation 
of the muscle metaboreflex can elicit increases in sympathetic activity and peripheral 
vasoconstriction (6, 29, 87), the mechanisms mediating vasodilation are unknown.  
Increases in sympathetic activity to the adrenal gland increases epinephrine release 
which can elicit substantial vasodilation, especially so in the skeletal muscle (8, 41, 45, 
46).  However, whether epinephrine release contributes to muscle metaboreflex-
induced peripheral vascular responses is unknown.  In the present study we tested the 
hypothesis that during metaboreflex activation epinephrine is released and causes β2-
mediated peripheral vasodilation. 
Methods 
Experimental subjects  
Eleven adult mongrel canines (~20-25 kg) of either sex were selected for the 
study.  All animals were acclimatized to the laboratory surroundings and willing to run 
on a motor-driven treadmill.  All the methods and procedures employed in the study 
were approved by the Institutional Animal Care and Use Committee (IACUC) of Wayne 
State University and complied with the National Institutes of Health Guide to the Care 
and Use of Laboratory Animals.  All animals exercised voluntarily during 
experimentation; no negative reinforcement techniques were utilized. 
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Surgical procedures 
For each of the two surgical procedures, the animals were sedated with 
acepromazine (0.4-0.5 mg/kg IM) and received preoperative analgesics [carprofen (2.0 
mg/kg IV), buprenorphine (0.01 mg/kg IM) and fentanyl (100-175 µg/h (72h) transdermal 
delivery)].  Anesthesia was induced with ketamine (5.0 mg/kg IV) and diazepam (0.22 
mg/kg IV) and maintained with isoflurane gas (1-3%).  For postoperative care, animals 
were closely monitored and given buprenorphine and acepromazine (0.05 and 0.5 
mg/kg IV, respectively) as needed.  To avoid acute postoperative infections, cefazolin 
(antibiotic, 30 mg/kg IV) was administered pre- and postoperatively.  Cephalexin 
(antibiotic, 30 mg/kg PO BID) was administered prophylactically for the entire term of 
the experimental protocol.  
In the first surgical procedure, the thoracic cavity was opened via a left 
thoracotomy (3rd/4th intercostal space) approach and the pericardium was cut to 
expose the heart.  A perivascular flow probe (20PAU, Transonic Systems) was placed 
around the ascending aorta to measure CO.  For studies unrelated to the present 
investigation, in some animals (n=6) a telemetry blood pressure transmitter (TA11 PA-
D70, DSI) was placed in the left ventricle, a flow probe was placed on the left circumflex 
artery (n=5) and pacing wires were secured to the free wall of the right ventricle (n=6) 
as described previously (29).  The pericardium was reapproximated, the wires were 
tunneled subcutaneously and exteriorized between the scapulae. The chest was closed 
in layers.  
In the second surgical procedure, an incision was made on the left flank cranial 
to the iliac crest to expose the abdominal aorta and left renal artery.  A perivascular flow 
probe (10PAU, Transonic Systems) was positioned around the terminal aorta to 
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measure hindlimb blood flow (HLBF).  For studies unrelated to the present investigation, 
a blood flow transducer was also placed on the left renal artery.  All side branches of the 
terminal aorta between the iliac arteries and the aortic flow probe were ligated and 
severed.  Two hydraulic occluders (8-10 mm, DocXS Biomedical Products) were placed 
around the terminal aorta just distal to flow probe and, for unrelated studies, a hydraulic 
occluder was also placed on the left renal artery.  A 19-gauge polyvinyl catheter (Tygon, 
S54-HL, Norton) was inserted into a side branch of the aorta cranial to the flow probe to 
measure systemic arterial pressure.  All instrumentation was tunneled subcutaneously 
and exteriorized between the scapulae and the abdomen was closed in layers.  Lastly, 
in some animals (n=6), a midline neck incision was made to expose and catheterize the 
right jugular vein for unrelated studies.   
Data acquisition 
Each animal was brought into the laboratory and allowed to roam freely and 
acclimate for ~10-20 minutes, following which it was directed onto the treadmill.  The 
flow probe cables were connected to flow meters (TS420, Transonic Systems).  The 
arterial catheter was aspirated, flushed and connected to a pressure transducer 
(Transpac IV, ICU Medical).  All hemodynamic variables were monitored as real-time 
waveforms by a data acquisition system (LabScribe, iWorx) and recorded for 
subsequent off-line analysis.  
Experimental procedures 
All experiments were performed after the animals had fully recovered from 
surgery (i.e., were active, afebrile and of good appetite).  Each experiment began with 
the animal standing still on the treadmill until all resting hemodynamic data were stable 
(typically 5-10 min).  The treadmill was turned on and the speed was gradually 
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increased to 3.2 kph at 0% grade.  The muscle metaboreflex was then engaged via 
graded reductions in HLBF via partial inflation of terminal aortic occluders.  Free-flow 
exercise and each level of vascular occlusion were maintained until all parameters 
reached steady state (typically 3-5 min).  In a subset of experiments in some animals 
(n=5), arterial blood samples were drawn for analysis of arterial epinephrine levels at 
rest, during free-flow exercise and at peak metaboreflex activation.  Epinephrine levels 
were measured by high-performance liquid chromatography with electrochemical 
detection (Waters, Milford, MA).  Control experiments (n=11) were repeated in the same 
animals after β-adrenergic blockade (2 mg/kg intra-arterial propranolol; n=7), α1-
adrenergic blockade (50 µg/kg intra-arterial prazosin; n=6) and α1+β blockade (n=6) on 
separate days.  The drugs were administered 30 minutes before each experiment and 
subsequent experiments were not performed for at least 48 hours. 
Data analysis 
Each animal served as its own control. CO, HLBF, heart rate (HR) and mean 
arterial pressure (MAP) were continuously recorded during each experimental 
procedure.  Other hemodynamic parameters were calculated during off-line data 
analysis (e.g., total vascular conductance (TVC) and non-ischemic vascular 
conductance (NIVC)).  TVC and NIVC were calculated as CO/MAP and (CO-
HLBF)/MAP, respectively.  One minute averages of all variables were taken during 
steady-state at rest, during free-flow exercise and after metaboreflex activation.  Mean 
values were averaged across all animals to obtain the sample mean of the study.  
Statistical analysis 
All hemodynamic data are reported as means ± SE.  An α-level of P<0.05 was 
used to determine statistical significance.  Averaged responses for each animal were 
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analyzed with Systat software (Systat 11.0).  A two-way ANOVA with repeated 
measures was used to compare hemodynamic data for time and/or conditional effects.  
In the event of a significant time-condition interaction, individual means were compared 
using the Test for Simple Effects. 
Results 
Figure 2.1 shows two minutes of steady state levels of MAP, CO, NIVC and 
HLBF during rest, mild (3.2 kph) exercise and muscle metaboreflex activation in a 
control experiment.  From rest to exercise, there is negligible change in MAP but a 
moderate increase in CO, NIVC and HLBF.  Muscle metaboreflex activation during 
exercise resulted in large increases in MAP and CO with a small increase in NIVC.  
 
Figure 2.1. Data from one control experiment showing mean arterial pressure (MAP), 
cardiac output (CO), non-ischemic vascular conductance (NIVC) and hindlimb blood flow 
(HLBF) during rest, exercise and metaboreflex activation. 
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Figure 2.2 shows the average arterial epinephrine levels during rest, mild 
exercise and metaboreflex activation in control experiments.  There was no change in 
epinephrine levels from rest to exercise, however with metaboreflex activation, arterial 
epinephrine levels increased by ~75%.  
REST EX MMA
A
rt
er
ia
l E
pi
ne
ph
rin
e
(p
g/
m
l)
0
30
60
90
120
150
180 *
 
Figure 2.3 shows mean values of MAP, CO, HR and NIVC during rest, mild 
exercise and metaboreflex activation in control and after β-blockade, α1-blockade and 
α1+β-blockade. 
Control (n=11).  MAP, CO, HR and NIVC significantly increased from rest to 
exercise and furthermore from exercise to muscle metaboreflex activation. 
β-adrenergic blockade (n=7).  CO, HR and NIVC significantly increased from rest 
to exercise, however the magnitudes of these responses were significantly lower when 
compared to control exercise levels.  There was no change in MAP from rest to 
exercise.  Muscle metaboreflex activation significantly increased MAP, CO and HR 
while NIVC was unaffected.  The magnitudes of responses during muscle metaboreflex 
activation for all parameters were significantly attenuated when compared to control 
Figure 2.2. Arterial epinephrine 
levels during rest, exercise (EX) and 
muscle metaboreflex activation 
(MMA) in control experiments (n=5). 
* p<0.05 vs. previous setting. 
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responses during metaboreflex activation.  
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Figure 2.3. Average values of MAP, CO, HR and NIVC during rest, exercise (EX) and 
muscle metaboreflex activation (MMA) in control experiments (open bars; n=11), after 
β-adrenergic blockade (hatched bars; n=7), α1-adrenergic blockade (crosshatched bars; 
n=6) and α1+β-blockade (filled bars; n=6). * p<0.05 vs. previous setting; † p<0.05 vs. 
control. 
α1-adrenergic blockade (n=6).  Resting MAP was significantly lower while HR 
was significantly higher when compared to control.  CO, HR and NIVC significantly 
increased from rest to exercise while there was no change in MAP.  Muscle 
metaboreflex activation caused substantial increases in all parameters.  Although HR 
and CO increased more than in control experiments, a larger rise in NIVC also occurred 
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and therefore the resultant pressor response was significantly attenuated.  
α1+β-blockade (n=6).  Resting CO was decreased when compared to control.  
From rest to exercise, MAP remained unchanged and CO, HR and NIVC significantly 
increased, although MAP and CO were still significantly lower than in control.  Muscle 
metaboreflex activation led to an increase in MAP while CO, HR and NIVC remained 
similar to exercise levels and significantly lower than in control.  
Discussion 
Our principal new finding is that activation of the muscle metaboreflex during mild 
dynamic exercise evokes increases in plasma epinephrine levels and subsequent β2-
mediated vasodilation which opposes α-adrenergic vasoconstriction.  Since β2-receptors 
are richly expressed in skeletal muscle, epinephrine release may partially restrain α-
adrenergic vasoconstriction of active skeletal muscle during metaboreflex activation, 
thereby improving blood flow to the ischemic active skeletal muscle. 
Muscle metaboreflex activation during dynamic exercise causes significant 
increases in MAP, HR, CO and ventricular contractility (6, 13, 16-18, 29, 43, 69-71, 95).  
However, the peripheral vascular responses have varied in previous studies. While 
significant vasoconstriction has been seen in the renal and forelimb vascular beds (6, 
29, 40, 48, 49) when taken as a whole, the total vascular conductance of all vascular 
beds except the hindlimbs (termed non-ischemic vascular conductance; NIVC) usually 
remains unchanged or slightly increases (6, 13, 40, 69, 78).  Inasmuch as some 
individual vascular beds do constrict, the observation of no change or slight increase in 
NIVC indicates that some area(s) vasodilate.  What causes this vasodilation has been 
unknown.  Reflex increases in sympathetic nerve activity can lead to increased pre-
ganglionic sympathetic activity to the adrenal glands which can cause substantial 
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increases in epinephrine release (8, 41, 45, 46).  In addition, post-ganglionic 
sympathetic nerve terminals have also been shown to release epinephrine (8, 41, 45, 
46).  Epinephrine is a powerful systemic vasodilator especially in skeletal muscle which 
is richly endowed with β2-adrenergic receptors (25, 42, 47, 86).  In the present study we 
saw that metaboreflex activation caused substantial increases in arterial plasma 
epinephrine levels.  A small, but statistically significant peripheral vasodilation occurred 
which was abolished by β-adrenergic blockade and accentuated by α1-adrenergic 
blockade.  These results support our hypothesis that muscle metaboreflex activation 
causes increases in circulating epinephrine which opposes α-mediated vasoconstriction 
via β2-mediated vasodilation.  Therefore, this mechanism can possibly explain the 
observed significant increase in NIVC.  Metaboreflex activation after combined α1+β-
blockade resulted in peripheral vasoconstriction which may be due to increased 
vasopressin release.  We previously demonstrated that the arterial baroreflex markedly 
suppresses metaboreflex-induced vasopressin release (57).  With α1+β-blockade the 
rise in arterial pressure with metaboreflex activation was lower thereby likely causing 
less baroreflex buffering of vasopressin release; similar to that previously observed in 
our laboratory after ganglionic blockade (57).  
What vascular beds are responsible for the small systemic vasodilation often 
seen with metaboreflex activation during dynamic exercise are not known.  Inasmuch as 
about 50% of total vascular conductance in dogs even at rest is skeletal muscle (28), it 
is likely that some muscle beds participate in these vasodilatory responses.  
Furthermore, skeletal muscle has a greater density of β2-adrenergic receptors than 
other beds such as the renal or mesenteric circulations.  It is also possible that the 
workload of some muscle groups is increased with metaboreflex activation.  Respiratory 
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muscles are potential candidates as metaboreflex activation may increase ventilation (4, 
43, 66).  Furthermore, with ischemia of the hindlimbs, there may also be an increase in 
work done by lumbar/gluteal muscles perfused by aortic branches not isolated in our 
preparation.  The coronary vasculature is also a likely target bed for the increased 
plasma epinephrine with muscle metaboreflex activation.  However, since the 
measurement of CO in our model does not include the coronary circulation (the 
coronary arteries arise from the ascending aorta below the CO blood flow transducer), 
β2-mediated coronary vasodilation did not contribute to the significant increase in NIVC.  
During exercise, the conductance of active skeletal muscle increases, and therefore 
skeletal muscle is also a likely target for β2-mediated vasodilation.  Our calculation of 
NIVC does not include the ischemic hindlimb vasculature, and therefore this vascular 
bed does not play a role in the observed vasodilation during metaboreflex activation in 
our model.  To what extent muscle metaboreflex activation (and potentially epinephrine) 
influences blood flow and vascular conductance to the ischemic active muscle is 
unknown. 
Limitations 
The plasma epinephrine levels were not measured during the experiments 
employing pharmacological approaches and it is possible that epinephrine levels were 
different in these settings than in the control experiments.  Norepinephrine released 
from sympathetic nerves could potentially also activate β-adrenergic receptors (as well 
as epinephrine activates α-adrenergic receptors).  However, a previous study 
demonstrated that norepinephrine infusion always caused vasoconstriction (31).  It is 
possible that after α-adrenergic blockade norepinephrine released from sympathetic 
nerves caused some dilation via activation of β-receptors.  The muscle metaboreflex is 
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buffered by the arterial baroreflex (40, 72) as well as by cardiac afferents (12) (and likely 
by other reflexes as well).  It is possible that the interaction between the metaboreflex 
and other reflexes may be affected by the pharmacological perturbations employed in 
the present study. 
Perspectives and significance 
Skeletal muscle is richly endowed with small group III/IV afferents which respond 
to changes in the mechanical and chemical environment, with many receptors being 
polymodal, e.g. some primarily mechano-receptors increase activity with ischemia (34, 
35).  Activation of skeletal muscle afferents by metabolite accumulation during ischemic 
exercise leads to increased sympathetic nerve activity eliciting a powerful pressor 
response.  The mechanisms mediating this pressor response may vary depending on 
the experimental paradigm.  When the metaboreflex is elicited during submaximal 
dynamic exercise via reductions in blood flow to the active skeletal muscle, the rise in 
MAP is virtually solely driven by increases in CO in both canines and humans (24, 32, 
68, 70).  In human studies the metaboreflex is often activated via the technique of post-
exercise circulatory occlusion after either static or dynamic limb exercise.  The data are 
mixed as to the relative roles of increases in CO vs. peripheral vasoconstriction and as 
we discussed in a previous study, this may be dependent on the intensity of contraction, 
type of exercise and the muscle mass involved (78).  When increases in CO are limited 
(e.g., maximal exercise, heart failure, etc.), metaboreflex activation leads to peripheral 
vasoconstriction (6, 16, 29, 32).  Since active skeletal muscle constitutes a progressively 
higher proportion of total vascular conductance with increasing exercise intensity, it 
becomes an increasingly more likely target for vasoconstriction in order to raise MAP.  
This vasoconstriction would further reduce blood flow and induce a larger degree of 
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ischemia in the active muscle causing heightened activation of the muscle 
metaboreflex, which in turn would cause a positive feedback cycle by further increasing 
the sympathetic tone.  In such situations, release of epinephrine from adrenal glands 
and/or post-ganglionic sympathetic nerve terminals causing β2-mediated vasodilation 
could act to protect perfusion of the active skeletal muscle.  
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CHAPTER 3 - MUSCLE METABOREFLEX ACTIVATION DURING DYNAMIC 
EXERCISE VASOCONSTRICTS THE ISCHEMIC ACTIVE SKELETAL MUSCLE 
(This Chapter contains previously published material. See Appendix C.) 
Abstract 
Metabolite accumulation due to ischemia of active skeletal muscle stimulates 
group III/IV chemosensitive afferents eliciting reflex increases in arterial blood pressure 
and sympathetic activity, termed the muscle metaboreflex.  We and others have 
previously demonstrated sympathetically-mediated vasoconstriction of coronary, renal 
and forelimb vasculatures with muscle metaboreflex activation (MMA).  Whether MMA 
elicits vasoconstriction of the ischemic muscle from which it originates is unknown.  We 
hypothesized that the vasodilation in the active skeletal muscle with imposed ischemia 
becomes progressively restrained by the increasing sympathetic vasoconstriction during 
MMA.  We activated the metaboreflex during mild dynamic exercise in chronically 
instrumented canines via graded reductions in hindlimb blood flow (HLBF) before and 
after α1-adrenergic blockade (prazosin; 50 µg/kg), β-adrenergic blockade (propranolol; 2 
mg/kg) and α1+β-blockade. Hindlimb resistance was calculated as femoral arterial 
pressure/HLBF.  During mild exercise, HLBF must be reduced below a threshold level 
before the reflex is activated. With initial reductions in HLBF, vasodilation occurred with 
the imposed ischemia.  Once the muscle metaboreflex was elicited, hindlimb resistance 
increased.  This increase in hindlimb resistance was abolished by α1-adrenergic 
blockade and exacerbated after β-adrenergic blockade.  We conclude that metaboreflex 
activation during submaximal dynamic exercise causes sympathetically-mediated α-
adrenergic vasoconstriction in the ischemic skeletal muscle.  This limits the ability of the 
reflex to improve blood flow to the muscle. 
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Introduction 
When O2 delivery to the active muscle is insufficient to meet the O2 demands, 
metabolites (e.g., hydrogen ions, adenosine, lactic acid, etc.) accumulate and activate 
chemosensitive group III and IV afferents (1, 9, 35, 43, 65, 75-77).  Activation of these 
sensory nerves elicits reflex increases in sympathetic outflow, heart rate (HR), cardiac 
output (CO), ventricular contractility and arterial blood pressure, termed the muscle 
metaboreflex (17, 32, 70, 76, 78, 88, 95).   
When the muscle metaboreflex is engaged in normal subjects during submaximal 
dynamic exercise, the reflex raises arterial blood pressure primarily by increasing CO 
(17, 32, 71, 74, 78).  This increase in CO raises the total blood flow available for tissue 
perfusion and thereby improves blood flow to the ischemic muscle (24, 56, 59, 68).  
O'Leary and Sheriff (59) concluded that metaboreflex-mediated increases in CO and 
arterial pressure restore about 50% of the blood flow deficit induced by imposed partial 
reductions in muscle blood flow during dynamic exercise in canines.  Similarly, Rowell 
et al. (68) concluded that metaboreflex activation during dynamic leg exercise in 
humans partially restores blood flow to the ischemic active muscle.  Sheriff et al. (73) 
concluded that the substances responsible for initiating the reflex accumulate due to 
reduced oxygen delivery rather than a failure of adequate washout.  As blood flow, and 
thereby the oxygen delivery, to the active muscle becomes insufficient, muscle afferent 
activity rises and the metaboreflex elicits increases in CO which partially restores the 
muscle blood flow.  Therefore, the muscle metaboreflex is often regarded as a flow-
sensitive, flow-raising reflex: engaged by suboptimal muscle blood flow and acting to 
increase total body blood flow (i.e., cardiac output) which partially restores blood flow to 
the underperfused active skeletal muscle (24, 56, 59, 68).  Recently, our laboratory 
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concluded that muscle metaboreflex activation induces epinephrine release causing β2-
mediated vasodilation within skeletal muscle (37).  This may be another potential 
mechanism which improves blood flow to the ischemic muscle during exercise.  
We and others have shown that metaboreflex activation elicits vasoconstriction of 
coronary, renal and forelimb vasculatures (3, 6, 13, 48, 49).  Further, Joyner (33) 
suggested that the muscle metaboreflex may vasoconstrict the ischemic active muscle 
as venous O2 saturation significantly declined with metaboreflex activation during 
rhythmic forearm exercise in humans.  Whether the muscle metaboreflex vasoconstricts 
the ischemic active muscle from which it originates is debatable (54).  The reflex 
increases in CO and MAP partially restore blood flow and oxygen delivery to the 
ischemic muscle (24, 56, 59, 68).  However, this restoration could be attenuated by 
vasoconstriction within the ischemic muscle.  To address this controversy, we 
investigated the changes in vascular tone within ischemic muscle during metaboreflex 
activation.  We hypothesized that with imposed reductions in skeletal muscle blood flow 
during exercise, metabolic vasodilation in the ischemic skeletal muscle would be 
progressively restrained by metaboreflex-mediated increase in sympathetic activity.  
This vasoconstriction would be attenuated after α-adrenergic blockade and potentiated 
after β-adrenergic blockade.  
Methods 
Experimental subjects 
Six adult mongrel canines (~19-24 kg) of either sex were selected for the study.  
All animals were acclimatized to the laboratory surroundings and willing to run on a 
motor-driven treadmill.  All methods and procedures employed in the study were 
approved by the Institutional Animal Care and Use Committee (IACUC) of Wayne State 
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University and complied with the National Institutes of Health Guide to the Care and 
Use of Laboratory Animals.  All animals exercised voluntarily during experimentation; no 
negative reinforcement techniques were utilized. 
Surgical procedures 
For each of the three surgical procedures, the animals were sedated with 
acepromazine (0.4-0.5 mg/kg IM) and received preoperative analgesics [carprofen (2.0 
mg/kg IV), buprenorphine (0.01 mg/kg IM) and fentanyl (75–125 µg/h (72h) transdermal 
delivery)].  Anesthesia was induced with ketamine (5.0 mg/kg IV) and diazepam (0.22 
mg/kg IV) and maintained with isoflurane gas (1–3%).  For postoperative care, animals 
were closely monitored and given acepromazine (0.5 mg/kg IV) and buprenorphine 
(0.05 mg/kg IV) as needed.  To avoid acute postoperative infections, cefazolin 
(antibiotic, 30 mg/kg IV) was administered pre- and post-operatively.  Cephalexin 
(antibiotic, 30 mg/kg PO BID) was administered prophylactically for the entire term of 
the experimental protocol. The animals recovered for two weeks after each surgery. 
In the first surgical procedure, the thoracic cavity was opened via a left 
thoracotomy (3rd/4th intercostal space) approach and the pericardium was cut to 
expose the heart.  A perivascular flow probe (20PAU, Transonic Systems) was placed 
around the ascending aorta to measure CO.  Due to the anatomical limitation for the 
aortic flow probe placement, coronary circulation is not included in the CO 
measurements.  In dogs at rest myocardial blood flow is approximately 6% of the total 
CO and this fraction remains relatively unchanged across workloads (27, 50).  A 
telemetry blood pressure transmitter (TA11 PA-D70, DSI) was tethered subcutaneously 
at the height of the left ventricular apex and two intercostal spaces caudal to the 
thoracotomy incision.  The tip of the pressure transducer catheter was inserted and 
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secured inside the left ventricle to measure left ventricular pressure.  Three pacing 
electrodes were secured to the right ventricular free wall for studies unrelated to the 
present investigation.  All wires were tunneled subcutaneously and exteriorized between 
the scapulae. The pericardium was reapproximated and the chest was closed in layers.  
In the second surgical procedure, an incision was made on the left flank cranial 
to the iliac crest to expose the abdominal aorta and left renal artery.  Perivascular flow 
probes (Transonic Systems) were positioned around the terminal aorta (10PAU) and the 
left renal artery (4PSB) to measure hindlimb blood flow (HLBF) and renal blood flow, 
respectively.  All side branches of the terminal aorta between the iliac arteries and the 
aortic flow probe were ligated and severed.  Two hydraulic occluders (8-10 mm, DocXS 
Biomedical Products) were placed around the terminal aorta just distal to the flow probe.  
A 19-gauge polyvinyl catheter (Tygon, S54-HL, Norton) was inserted into a side branch 
of the aorta cranial to the flow probe to measure systemic arterial pressure.  A second 
19-gauge polyvinyl catheter was inserted into a side branch of the aorta caudal to the 
occluders to measure arterial pressure below the occluders.  When the catheterization 
of a caudal aortic branch was not possible in this surgery, a catheter was placed into a 
side branch of the femoral artery in a third procedure.  All instrumentation was tunneled 
subcutaneously and exteriorized between the scapulae and the abdomen was closed in 
layers.  For experiments unrelated to this study, a catheter was inserted into the right 
jugular vein (n=2) and a hydraulic occluder was placed around each common carotid 
artery in a separate procedure.  
Data acquisition 
Each animal was brought into the laboratory and allowed to roam freely and 
acclimate for ~10-20 minutes, following which it was directed onto the treadmill.  The 
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flow probe cables were connected to flow meters (TS420, Transonic Systems).  The two 
arterial catheters were aspirated, flushed and connected to pressure transducers 
(Transpac IV, ICU Medical).  All hemodynamic variables were monitored as real-time 
waveforms by a data acquisition system (LabScribe2, iWorx) and recorded for 
subsequent off-line analysis.  
Experimental procedures 
All experiments were performed after the animals had fully recovered from 
surgery (i.e., were active and of good appetite).  Each experiment began with the animal 
standing still on the treadmill until all resting hemodynamic data were stable (typically 5-
10 min).  The treadmill was turned on and the speed was gradually increased to 3.2 kph 
at 0% grade.  To activate the muscle metaboreflex, HLBF was reduced to ~40% of free-
flow exercise levels via graded reductions (by partial inflation of terminal aortic 
occluders).  Free-flow exercise and each level of vascular occlusion were maintained 
until all hemodynamic parameters reached steady state (typically 3-5 min).  Control 
experiments were repeated in the same animals after α1-adrenergic blockade (prazosin 
50 µg/kg intra-arterial), β-adrenergic blockade (propranolol 2 mg/kg intra-arterial) and 
α1+β blockade on separate days.  The drugs were administered 20-30 minutes before 
the experiment and subsequent experiments were not performed for at least 48 h.  The 
large vasoconstrictor effect of phenylephrine was completely abolished with 50 µg/kg 
dose of prazosin.  Preliminary studies showed that 2 mg/kg dose of propranolol 
completely abolished the vasodilatory response caused by isoproterenol (0.5 µg/kg).  
Animals performed the same exercise workload after each blockade as during control 
experiments. 
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Data analysis 
Mean arterial pressure (MAP), femoral arterial pressure (FAP), HR, CO and 
HLBF were continuously recorded during each experimental procedure. Hindlimb 
vascular resistance was calculated as FAP/HLBF.  Vascular conductance to all vascular 
beds with the exception of the hindlimb (termed non-ischemic vascular conductance, 
NIVC) was calculated as NIVC = (CO-HLBF)/MAP.  One minute averages of all 
variables were taken during steady-state at rest, free-flow exercise and each graded 
reduction in HLBF.  The data were analyzed as initially described by Wyss et al. (95).  
Previous studies have shown that during mild exercise in canines HLBF must be 
reduced below a clear threshold before the muscle metaboreflex is activated (6, 73, 95).  
Initial reductions in HLBF did not evoke metaboreflex responses while reductions in 
HLBF below the threshold resulted in a significant pressor response.  Therefore, the 
data were approximated to two linear regression lines: an initial slope line that includes 
free-flow exercise and each reduction in blood flow that did not elicit reflex response, 
and a pressor slope line that includes reductions in HLBF that resulted in a large 
pressor response (Figure 3.2).  The threshold for metaboreflex activation was 
approximated as the intersection of the initial and pressor slope lines.  Mean values 
were averaged across all animals to obtain the sample mean of the study.  Each animal 
served as its own control. 
Statistical analysis 
All hemodynamic data are reported as means ± SE.  An α-level of P<0.05 was 
used to determine statistical significance.  Averaged responses for each animal were 
analyzed with Systat software (Systat 11.0).  A two-way ANOVA with repeated 
measures was used to compare hemodynamic data for time and/or condition effects.  In 
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the event of a significant time-condition interaction, individual means were compared 
using the Test for Simple Effects. 
Results 
Figure 3.1 shows 5 second averages of MAP, CO, HLBF and hindlimb resistance 
in a control experiment during rest, mild (3.2 kph) exercise and graded reductions in 
HLBF.  From rest to exercise, hindlimb resistance decreased and HLBF increased along 
with the rise in CO. Initial graded reductions in HLBF did not evoke changes in MAP or 
CO, but caused further decreases in hindlimb resistance. When reductions in HLBF 
elicited the metaboreflex, marked increases in MAP and CO occurred and despite the 
continued progressive hindlimb ischemia, hindlimb vascular resistance rose indicating 
that vasoconstriction occurred.  
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Figure 3.1. Data from one control experiment showing mean arterial pressure (MAP), 
cardiac output (CO), hindlimb blood flow (HLBF), and hindlimb resistance during rest, 
exercise (Ex) and graded reductions in HLBF eliciting the muscle metaboreflex.  
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Figure 3.2. The initial and pressor slopes 
of mean arterial pressure (top panel) and 
hindlimb resistance (bottom panel) 
obtained by dual linear regression model 
from a control experiment.  
 
 
 
 
 
 
 
Figure 3.2 shows the relationships between MAP vs. HLBF (top) and hindlimb 
resistance vs. HLBF (bottom) from a control experiment.  Figure 3.3 shows average 
hindlimb resistance responses as a function of HLBF in control, after α1-adrenergic 
blockade, β-adrenergic blockade and α1+β-blockade. 
 
Figure 3.3. Hindlimb resistance responses during free-flow exercise, metaboreflex 
threshold and maximal metaboreflex activation (n=6) for control (open circles) vs. α1-
blockade (filled triangles) (left), control vs. β-blockade (filled squares) (center) and 
control vs. α1+β-blockade (filled diamonds) (right). * p<0.05 vs. previous setting in same 
experiment; † p<0.05 vs. control setting. 
Control.  Initial reductions in HLBF caused a significant decrease in hindlimb 
vascular resistance.  Once HLBF was reduced below threshold, there was a significant 
increase in hindlimb resistance.   
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α1-adrenergic blockade.  Initial HLBF reductions above the threshold caused a 
significant decrease in hindlimb resistance as in control.  However, when HLBF was 
reduced below threshold, the increase in resistance observed in control was abolished 
revealing a continued decrease in resistance.  The magnitude of hindlimb resistance 
during maximal metaboreflex activation was significantly lower than control. 
β-adrenergic blockade. During free-flow exercise, hindlimb resistance was 
significantly higher than control. With initial reductions in HLBF, hindlimb resistance 
significantly decreased to a level not different from control. Following metaboreflex 
activation, there was a significant increase in hindlimb resistance. The magnitude of 
resistance at maximal metaboreflex activation was significantly larger than in control. 
α1+β-blockade.  With initial reductions in HLBF, hindlimb resistance decreased to 
a level not different from control.  Following metaboreflex activation, there was a small 
increase in hindlimb resistance which was not different from control.    
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Figure 3.4. Initial and pressor slope responses of hindlimb vascular resistance during 
muscle metaboreflex activation (n=6) in control (open bars), after α1-adrenergic 
blockade (hatched bars), β-adrenergic blockade (cross-hatched bars), and α1+β-
blockade (filled bars). * p<0.05 vs. initial slope; † p<0.05 vs. control setting. 
Figure 3.4 shows average slopes of the relationship between hindlimb vascular 
resistance vs. hindlimb blood flow during the initial and pressor responses in control and 
following α1-blockade, β-blockade and α1+β-blockade.  In control, the initial slope was 
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significantly different from the pressor slope.  After α1-adrenergic blockade, the initial 
and pressor slopes were not significantly different from each other.  The initial slope 
after α1-blockade was similar to that in control while the pressor slope was reversed and 
significantly different from control.  After β-blockade, the initial and pressor slopes were 
significantly different from each other and the pressor slope was markedly larger (more 
negative) than in control.  After α1+β-blockade, the two slopes were significantly 
different from each other but not from control. 
Table 3.1. Mean hemodynamic values during rest, mild exercise (EX) and muscle 
metaboreflex activation (MMA) in control and after α1-blockade, β-blockade and α1+β-
blockade in normal animals. 
      Control  α1-blockade  β-blockade α1+β-blockade 
MAP Rest 88.4 ± 1.9 81.4 ± 1.4 † 84.4 ± 2.2 76.9 ± 2.0 † 
(mmHg) Ex 92.1 ± 1.2 * 83.5 ± 1.6 *† 90.3 ± 3.5 * 81.5 ± 1.9 † 
  MMA 143.6 ± 1.6 * 119.5 ± 3.4 *† 114.4 ± 5.4 *† 113.7 ± 4.8 *† 
CO Rest 2.75 ± 0.15 2.87 ± 0.18 2.59 ± 0.10 2.70 ± 0.16 
(l/min) Ex 4.32 ± 0.23 * 4.48 ± 0.21 *  3.71 ± 0.25 *† 4.03 ± 0.24 * 
  MMA 6.50 ± 0.27 * 6.66 ± 0.21 *  4.11 ± 0.23 *† 4.71 ± 0.32 *† 
HR Rest 69.9 ± 4.2 83.2 ± 5.5 † 70.4 ± 3.1 80.3 ± 4.4 
(bpm) Ex 101.0 ± 2.8 * 112.9 ± 4.8 *† 95.3 ± 1.0 *† 106.6 ± 4.7 * 
  MMA 141.0 ± 3.6 * 159.4 ± 8.6 *† 104.3  ± 4.3 † 119.6 ± 6.7 *† 
NIVC Rest 24.3 ± 1.3 28.1 ± 2.2 † 24.6 ± 1.2 27.9 ± 1.8 † 
(ml/min/mmHg) Ex 34.2 ± 1.7 * 39.6 ± 2.6 *† 29.7 ± 1.3 *† 36.3 ± 1.7 * 
  MMA 41.4 ± 1.7 * 50.8 ± 1.7 *† 31.5 ± 1.3 † 36.4 ± 1.9 † 
HLBF Rest 0.60 ± 0.07 0.60 ± 0.04 0.52 ± 0.05 0.55 ± 0.04 
(l/min) Ex 1.18 ± 0.13 * 1.20 ± 0.09 * 1.02 ± 0.12 *† 1.07 ± 0.13 * 
  MMA 0.55 ± 0.04 0.64 ± 0.05 † 0.52 ± 0.04 0.56 ± 0.04 
Mean hemodynamic values during rest, free-flow exercise and maximal metaboreflex activation during 
control experiments and following α1-blockade, β-blockade and α1+β-blockade in six animals, represented 
as means ± SE. MAP, mean arterial pressure; CO, cardiac output; HR, heart rate; NIVC, non-ischemic 
vascular conductance; HLBF, hindlimb blood flow; *P<0.05 vs. previous setting in same experiment; 
†P<0.05 vs. control. 
 
Table 3.1 shows mean hemodynamic data during rest, mild exercise and muscle 
metaboreflex activation in control experiments and following α1-blockade, β-blockade 
and α1+β-blockade.  From rest to exercise in control, there were significant increases in 
MAP, CO, HR, NIVC and HLBF.  With muscle metaboreflex activation, there were 
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further significant increases in MAP, CO, HR and NIVC.  Following α1-adrenergic 
blockade, resting MAP was significantly lower while HR and NIVC were significantly 
higher than in control.  With mild exercise there was a significant increase in all 
variables and MAP, HR and NIVC were significantly higher than control exercise levels.  
Muscle metaboreflex activation following α1-blockade resulted in substantial increases 
in MAP, CO, HR and NIVC with a significantly attenuated pressor response compared 
to control.  Following β-adrenergic blockade, all the parameters increased with exercise 
but the levels of CO, HR, NIVC and HLBF were significantly lower than those observed 
during control experiments.  Muscle metaboreflex activation significantly increased 
MAP, CO, and HR while NIVC was unchanged and all parameters were significantly 
attenuated compared with metaboreflex responses in control.  Following α1+β-blockade, 
resting MAP and NIVC was lower than in control.  From rest to exercise, CO, HR, NIVC 
and HLBF significantly increased while MAP remained unchanged and was significantly 
lower than in control.  Muscle metaboreflex activation led to an increase in MAP, CO 
and HR but all responses were significantly lower than in control.  
Discussion 
The major new finding of this study is that muscle metaboreflex-induced 
increases in sympathetic activity cause vasoconstriction of the ischemic active skeletal 
muscle from which the metaboreflex originates.  Inasmuch as metaboreflex-induced 
increases in CO and arterial blood pressure partially restore blood flow to the ischemic 
muscle, sympathetically-mediated vasoconstriction would limit the ability of the 
metaboreflex to improve blood flow to the ischemic muscle.  
The muscle metaboreflex is activated when oxygen supply to the muscle is 
unable to meet the metabolic demands of the active muscle (73, 95).  During mild 
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exercise in canines, initial reductions in HLBF did not cause any marked increases in 
MAP, CO or HR, indicating adequate oxygen supply to the working muscle.  With further 
reductions in HLBF oxygen supply becomes insufficient to meet the oxygen demand of 
the active muscle leading to accumulation of metabolites (H+, lactic acid, diprotonated 
phosphate, etc.) (9, 65, 75-77).  As a result, the muscle metaboreflex is activated and 
marked elevations in MAP, CO, HR and ventricular contractility are observed (13, 16, 
17, 70, 78, 95).  Thus, during mild dynamic exercise in canines there is a clear threshold 
before the muscle metaboreflex is activated (Figure 3.2).  
In control, initial reductions in HLBF resulted in metabolic vasodilation as 
indicated by a decrease in hindlimb vascular resistance (Figure 3.3).  When reductions 
in HLBF below the threshold elicited the metaboreflex, metabolic vasodilation was 
opposed by vasoconstriction as indicated by an increase in vascular resistance within 
the ischemic muscle.  Following α1-blockade, the vasoconstriction observed during 
metaboreflex activation in control was abolished, revealing a continued vasodilation in 
the ischemic vasculature with further reductions in hindlimb blood flow.  These findings 
indicate that muscle metaboreflex activation induces α1-mediated sympathetic 
vasoconstriction within the ischemic skeletal muscle.  After β-blockade, metaboreflex 
activation caused a significantly larger vasoconstriction in the hindlimb vasculature than 
in control.  These findings are in agreement with our previous work demonstrating 
metaboreflex-induced β2-mediated vasodilation in ischemic skeletal muscle (37).  
Following α1+β-blockade, metaboreflex activation resulted in a vasoconstriction not 
significantly different from control.  This could be due to the contribution of other 
hemodynamic factors such as vasopressin, endothelin, neuropeptide Y etc., and/or a 
potential α2-mediated vasoconstriction (7, 10, 19, 30, 57).  Therefore, vasomotor tone of 
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the ischemic muscle with muscle metaboreflex activation during submaximal exercise is 
a combined result of a complex interplay between metabolic vasodilation and 
neurogenic and circulating vasoconstrictor factors as well as possible local factors 
released from the endothelium.  In the control experiments, the prevailing neurogenic 
vasoconstriction results in frank vasoconstriction within the ischemic vasculature.  
We and others have shown that metaboreflex activation elicits vasoconstriction of 
coronary, renal and forelimb vasculatures (3, 6, 13, 48, 49).  Whether the muscle 
metaboreflex vasoconstricts the ischemic muscle itself has been controversial (33, 54, 
59).  Muscle metaboreflex activation during dynamic exercise in canines markedly 
increases MAP and CO which restores about half of the blood flow deficit to the 
ischemic skeletal muscle (59).  In humans, Rowell et al. (68) showed that metaboreflex 
activation in normal subjects partially restores blood flow to ischemic muscle.  Eiken and 
Bjurstedt (24) reached similar conclusions whereas Joyner (33) suggested that a reflex-
induced sympathetic vasoconstriction in the ischemic muscle limits the restoration of 
blood flow.  Several factors could contribute to these conflicting findings: 1) the studies 
performed in humans did not directly measure blood flow, blood pressure or 
sympathetic nerve activity within the active skeletal muscle, 2) the exercise intensity, 
muscle mass and muscle type involved in the exercise were different and 3) species 
differences may exist in the extent of metaboreflex activation (2, 6, 68, 95).  This is the 
first study to directly measure arterial pressure and blood flow within the ischemic active 
muscle.  We show that metaboreflex activation induces α1-mediated sympathetic 
vasoconstriction within the ischemic active muscle.  If no sympathetic vasoconstriction 
occurred with metaboreflex activation, the amount of blood flow restoration to the 
ischemic vasculature would have been larger than 50%.  Therefore, muscle 
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metaboreflex-induced neurogenic vasoconstriction limits the ability of the reflex to 
restore blood flow to the muscle. 
Vasoconstriction within the ischemic muscle would result in a decrease in muscle 
blood flow which would lead to exaggerated metaboreflex activation. Therefore, this 
becomes a positive feedback loop wherein vasoconstriction decreases the blood flow to 
the already ischemic muscle, further activating muscle afferents and causing a larger 
vasoconstriction.  However, the positive feedback could either become run-away 
positive feedback, where each cycle would lead to exaggerated metaboreflex activation 
and a larger vasoconstriction, or become limiting positive feedback, where the stimulus 
and the response progressively become smaller and reach a plateau.  Whether this 
positive feedback loop becomes a run-away cycle of continuing amplified responses or 
serves as an amplifier of the initial responses which reaches a plateau depends on the 
magnitude of the change in sympathetic activity engendered by the reflex and the 
efficacy of this change in sympathetic activity on blood flow to the ischemic muscle.   
That is, if the rise in sympathetic activity elicited by a one unit decrease in muscle blood 
flow evokes vasoconstriction in the muscle which causes a less than one unit fall in 
flow, then the positive feedback will cycle with ever decreasing amplitude and eventually 
plateau at a heightened response.  If however, the fall in blood flow caused by the rise 
in sympathetic activity is greater than the change in flow which caused the rise in 
sympathetic activity itself, then this becomes a “run-away” positive feedback with ever 
increasing responses eventually leading to complete vasoconstriction.  Using the 
average results in our study, the pressor slope for the relationship between the imposed 
decrease in HLBF and the observed increase in hindlimb vascular resistance was -36 
units which indicates that for every l/min decrease in flow, there would be a 36 
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mmHg/l/min increase in resistance.  This 36 mmHg/l/min increase in resistance caused 
by metaboreflex activation would itself cause a decrease in flow.  At the threshold level 
of HLBF, an increase in hindlimb resistance by 36 mmHg/l/min would cause a 0.54 l/min 
further decrease in flow if pressure remained constant.  This decrease in flow would 
additionally increase resistance by 19.7 mmHg/l/min which in turn would decrease flow 
by 0.15 l/min and so forth.  With each cycle, the increase in the stimulus and the 
resultant reflex response becomes progressively smaller and the positive feedback will 
eventually reach a steady state.  Whereas a variety of factors can affect the hindlimb 
resistance response, our results indicate that this is a limiting positive feedback which is 
a stable system resulting in amplified gain rather than run-away instability. 
In canines, nearly half of the CO at rest perfuses skeletal muscle (28) and during 
exercise all of the rise in CO is directed to the active skeletal muscle (50).  When further 
increases in CO become limited (e.g., during severe exercise, heart failure, following β-
blockade, etc.), peripheral vasoconstriction is the only mechanism available to increase 
arterial pressure.  Since the active skeletal muscle constitutes a large proportion of total 
vascular conductance during severe exercise, the ischemic active muscle is the likely 
target for progressively larger vasoconstriction.  Several studies indicate that metabolic 
by-products in skeletal muscle reduce neurogenic vasoconstriction, termed functional 
sympatholysis (63, 85).  Although to some extent conclusions may also be dependent 
on methods of data analysis (52).  In patho-physiological states functional 
sympatholysis may be reduced (85, 90) which may thereby heighten vasoconstrictor 
responses in the ischemic muscle in these settings.  This would further limit O2 delivery 
to the ischemic muscle leading to an exaggerated activation of the muscle 
metaboreflex, stimulating a dangerous positive feedback loop.  To what extent this 
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metaboreflex positive feedback approaches run-away levels in pathophysiological 
states is unknown.  Fundamentally, this feedback could impair the ability to exercise 
and contribute to exercise intolerance.  
Limitations 
The arterial baroreflex buffers about one-half of the muscle metaboreflex-induced 
pressor response and this occurs primarily by inhibition of peripheral vasoconstriction 
(40).  In our study, MAP during muscle metaboreflex activation after α1- and β-blockade 
was significantly smaller than in control.  This lower arterial pressure could potentially 
result in a reduced buffering by the baroreflex and cause larger metaboreflex-induced 
peripheral vasoconstriction.  A larger vasoconstrictor drive could limit the hindlimb 
vasodilation we observed with metaboreflex activation after α1-blockade and could 
exaggerate the vasoconstriction we observed after β-blockade.  Our observation of 
continued hindlimb vasodilation after α1-blockade despite possible larger sympathetic 
activation would argue in favor of our conclusion that sympathetic vasoconstriction 
occurs in the ischemic hindlimb during metaboreflex activation.  The larger 
vasoconstriction seen after β-blockade may have been exaggerated due to the lower 
arterial pressure and less baroreflex buffering of the metaboreflex responses. 
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CHAPTER 4 - MUSCLE METABOREFLEX-INDUCED VASOCONSTRICTION OF THE 
ISCHEMIC ACTIVE MUSCLE IS EXAGGERATED IN HEART FAILURE 
Abstract 
When oxygen delivery to active muscle is insufficient to meet metabolic 
demands, metabolites accumulate and stimulate skeletal muscle afferents inducing a 
reflex rise in blood pressure, termed the muscle metaboreflex.  Muscle metaboreflex 
activation (MMA) during submaximal dynamic exercise increases arterial pressure 
virtually solely via an increase in cardiac output (CO), as no net peripheral 
vasoconstriction occurs.  In heart failure (HF), increases in CO are limited and 
metaboreflex-induced pressor responses occur via peripheral vasoconstriction.  We 
recently demonstrated that MMA induces sympathetic vasoconstriction in the ischemic 
active muscle, limiting the ability of the metaboreflex to restore blood flow.  In the 
present study we tested the hypothesis that vasoconstriction in the ischemic muscle is 
exaggerated in HF.  Changes in hindlimb vascular resistance (femoral arterial 
pressure/hindlimb blood flow (HLBF)) were observed during MMA induced via graded 
reductions in HLBF during mild exercise with and without α1-adrenergic blockade 
(prazosin; 50 µg/kg) before and after the induction of HF.  During mild exercise, HLBF 
must be reduced below a clear threshold before MMA occurs. In normal animals, initial 
HLBF reductions caused metabolic vasodilation while reductions below the MMA 
threshold elicited reflex vasoconstriction in the ischemic muscle which was abolished 
following α1-adrenergic blockade.  MMA-induced vasoconstriction of the ischemic 
muscle was exaggerated after induction of HF.  This heightened vasoconstriction 
impairs the ability of the metaboreflex to restore blood flow to ischemic muscle in HF 
and may contribute to exercise intolerance observed in these patients.  We conclude 
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that sympathetically-mediated vasoconstriction of the ischemic skeletal muscle during 
muscle metaboreflex activation is exaggerated in HF.  
Introduction 
Ischemia in the exercising skeletal muscle causes accumulation of metabolites 
(e.g., protons, diprotonated phosphate, lactic acid, etc.) which activate the 
chemosensitive muscle afferents eliciting a reflex pressor response, termed the muscle 
metaboreflex (1, 9, 35, 77).  Muscle metaboreflex activation in healthy individuals 
increases heart rate (HR), cardiac output (CO), mean arterial pressure (MAP), 
ventricular contractility and right atrial pressure (17, 70, 71, 78, 88) along with some 
regional vasoconstriction (6, 13, 48, 49). 
During submaximal dynamic exercise in normal subjects, muscle metaboreflex-
induced pressor response, primarily driven by an increase in CO (6, 17, 32), partially 
restores blood flow to ischemic active muscle (24, 59, 70).  Muscle metaboreflex-
induced epinephrine release resulting in β2-mediated vasodilation within the skeletal 
muscle (37) is another viable mechanism for blood flow restoration to ischemic active 
muscle.  We recently showed however, that the very muscle from which the muscle 
metaboreflex originates is itself a target vasculature for sympathetically-mediated 
vasoconstriction during muscle metaboreflex activation (36).  This functionally limits the 
ability of metaboreflex to restore blood flow to the ischemic muscle. 
The strength and mechanisms of metaboreflex activation are altered in heart 
failure (HF) (14, 29, 51, 81).  HF is characterized by low resting CO and heightened 
sympathetic nerve activity (SNA).  Inasmuch as metaboreflex-induced increases in CO 
and ventricular contractility are substantially attenuated in HF, the pressor response 
occurs due to enhanced vasoconstriction of the peripheral vasculature (14, 16, 29, 58).  
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Whether the ischemic muscle itself undergoes exaggerated reflex vasoconstriction is 
unknown.  Therefore, in this study, we investigated whether the vasoconstriction in the 
ischemic active skeletal muscle is exaggerated in HF.  
Methods 
Experimental subjects 
Six adult mongrel canines (~19-24 kg) of either sex were selected for the study 
for their willingness to walk on a motor-driven treadmill.  All methods and procedures 
employed in the study were approved by the Institutional Animal Care and Use 
Committee (IACUC) of Wayne State University and complied with the National Institutes 
of Health Guide to the Care and Use of Laboratory Animals.  All animals were 
acclimatized to the laboratory surroundings and exercised voluntarily during 
experimentation; no negative reinforcement techniques were utilized. 
Surgical procedures 
For each surgical procedure, anesthesia was induced with ketamine (5 mg/kg IV) 
and diazepam (0.2-0.3 mg/kg IV) and maintained with isoflurane gas (1–3%).  The 
animals received preoperative analgesics [carprofen (4.4 mg/kg IV), buprenorphine 
(0.01-0.03 mg/kg IM) and fentanyl (75–125 µg/h (72h) transdermal delivery)].  
Acepromazine (0.2-0.3 mg/kg IV) and buprenorphine (0.01-0.03 mg/kg IM) was given 
during postoperative care.  To avoid acute postoperative infections, cefazolin (antibiotic, 
30 mg/kg IV) was administered pre- and post-operatively.  Cephalexin (antibiotic, 30 
mg/kg PO BID) was administered prophylactically for the entire term of the experimental 
protocol. 
In the first surgical procedure, the heart was exposed via a left thoracotomy 
(3rd/4th intercostal space) approach.  A 20 mm blood flow transducer (Transonic 
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Systems) was placed around the ascending aorta to measure CO.  A telemetry 
pressure transmitter (TA11 PA-D70, DSI) was tethered subcutaneously and its tip was 
secured inside the left ventricle to measure left ventricular pressure.  Three stainless 
steel pacing electrodes (0-Flexon) were secured to the right ventricle.  All wires were 
tunneled subcutaneously and exteriorized between the scapulae. The chest was closed 
in layers after reapproximating the pericardium.  
In the second surgical procedure, the abdominal aorta was exposed via a left 
flank incision cranial to the iliac crest.  A 10 mm blood flow transducer (Transonic 
Systems) was placed around the terminal aorta to measure hindlimb blood flow (HLBF) 
and two hydraulic occluders (8-10 mm, DocXS Biomedical Products) were placed just 
distal to it.  All side branches of the terminal aorta between the iliac arteries and the 
aortic flow probe were ligated.  A 19-gauge polyvinyl catheter (Tygon, S54-HL, Norton) 
was inserted into a side branch of the aorta to measure systemic arterial pressure.  A 
second 19-gauge polyvinyl catheter was inserted into a side branch of the aorta caudal 
to the occluders to measure arterial pressure below the occluders.  When the 
catheterization of a caudal aortic branch was not possible in this surgery, a catheter was 
placed into a side branch of the femoral artery in a separate procedure.  All 
instrumentation was tunneled subcutaneously and exteriorized between the scapulae.  
The abdomen was closed in layers.  For experiments unrelated to this study, a 4 mm 
flow probe was placed around the left renal artery during retroperitoneal surgery and 
hydraulic occluders were placed around common carotid arteries in a separate 
procedure. 
Data acquisition 
Before each experiment, the animal was brought into the laboratory and allowed 
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to roam freely and acclimate for ~10-20 minutes.  Then, the animal was led to the 
treadmill, arterial catheters were connected to pressure transducers, left ventricular 
telemetry implant was turned on and flow probes were connected to flow meters 
(Transonic Systems).  All hemodynamic variables were monitored as real-time 
waveforms by a data acquisition system (LabScribe2, iWorx) and recorded for 
subsequent off-line analysis.  
Experimental procedures 
Animals recovered for at least two weeks after each surgery.  Experiments were 
performed after the animals had fully recovered from surgery (i.e., were active and of 
good appetite).  During each experiment, resting steady-state hemodynamic parameters 
were recorded with the animal standing on the treadmill followed by mild exercise (3.2 
kph at 0% grade).  The muscle metaboreflex was activated via graded reductions in 
HLBF (by partial inflation of terminal aortic occluders) during mild exercise.  Free-flow 
exercise and each reduction in HLBF were maintained until all hemodynamic 
parameters reached steady state (~3-5 min).  Control experiments were repeated in the 
animals after α1-adrenergic blockade (prazosin 50 µg/kg intra-arterial).  The drug was 
administered 20-30 minutes before the experiment and no subsequent experiments 
were performed for next 48 hours.  In each experiment, the dose of prazosin was 
sufficient to abolish the large vasoconstrictor effect of phenylephrine (4 µg/kg).  After the 
completion of experiments in normal animals, heart failure was induced via rapid 
ventricular pacing (220-240 beats/min) for a group average of 32 ± 4 days.  The 
development of HF was established by resting tachycardia and decreases in resting 
mean arterial pressure (MAP), CO, maximal rate of the rise in left-ventricular pressure 
(dP/dtmax) and maximal rate of fall in left-ventricular pressure (dP/dtmin) (Table 4.1). 
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Data analysis 
MAP, femoral arterial pressure (FAP), HR, CO, left ventricular pressure and 
HLBF were continuously recorded during each experimental procedure.  Hindlimb 
vascular resistance was calculated as FAP/HLBF. Vascular conductance to all vascular 
beds except the hindlimb (termed non-ischemic vascular conductance, NIVC) was 
calculated as NIVC = (CO-HLBF)/MAP.  One minute averages of all variables were 
taken during steady-state at rest, free-flow exercise and each graded reduction in 
HLBF.  Inasmuch as the HLBF during mild exercise in canines must be reduced below a 
clear threshold before the muscle metaboreflex is activated (6, 73, 95), initial reductions 
in HLBF did not evoke any metaboreflex responses while reductions in HLBF below the 
threshold resulted in a significant pressor response.  Therefore, the data were 
approximated to two linear regression lines: an initial slope line that includes free-flow 
exercise and each reduction in blood flow that did not elicit reflex response, and a 
pressor slope line that includes reductions in HLBF that resulted in large pressor 
response (Figure 4.2).  The threshold for metaboreflex activation was approximated as 
the intersection of the initial and pressor slope lines.  Mean values were averaged 
across all animals to obtain the sample mean of the study.  Each animal served as its 
own control. 
Statistical analysis 
All hemodynamic data are reported as means ± SE. An α-level of P<0.05 was 
used to determine statistical significance.  Averaged responses for each animal were 
analyzed with Systat software (Systat 11.0).  A two-way ANOVA with repeated 
measures was used to compare hemodynamic data for time and/or condition effects.  In 
the event of a significant time-condition interaction, individual means were compared 
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using the Test for Simple Effects. 
Results 
Figure 4.1 MAP, CO and HLBF in a control experiment during rest, mild exercise 
and muscle metaboreflex activation induced by graded reductions in HLBF (data are 
averaged over every 5 seconds for clarity).  From rest to exercise, MAP remained 
unchanged while CO and HLBF increased.  With initial graded reductions in HLBF, 
there was a small increase in both MAP and CO.  When further reductions in HLBF 
elicited the muscle metaboreflex, marked increases in MAP and CO occurred.  Figure 
4.2 shows the relationships between MAP vs. HLBF and hindlimb resistance vs. HLBF 
during the control experiment.  Initial reductions in HLBF caused a small increase in 
MAP and a decrease in hindlimb resistance.  Once metaboreflex threshold is reached, 
further reductions in HLBF caused large reflex increase in MAP and hindlimb 
resistance.  
Figure 4.1. Data from 
one control experiment 
showing mean arterial 
pressure, cardiac output 
and hindlimb blood flow 
during rest, mild free-flow 
exercise (Ex) and muscle 
metaboreflex activation 
(MMA) induced via 
graded reductions in 
hindlimb blood flow.  
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Figure 4.2. Initial and pressor slopes 
of mean arterial pressure (top) and 
hindlimb resistance (bottom) obtained 
by using dual linear regression model 
in a control experiment. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 shows average hindlimb resistance responses as a function of HLBF 
in control and α1-adrenergic blockade experiments before and after induction of HF.  
During control experiments in healthy animals, initial reductions in HLBF caused a 
significant decrease in hindlimb vascular resistance, indicating vasodilation in the 
hindlimb skeletal muscle.  Once HLBF was reduced below threshold, there was a 
significant increase in hindlimb resistance indicating vasoconstriction of the ischemic 
skeletal muscle.  Following α1-adrenergic blockade, initial HLBF reductions caused a 
similar decrease in hindlimb resistance as in control.  However, once HLBF was 
reduced below threshold, the vasoconstriction observed in control was completely 
abolished, hindlimb resistance continued to fall with further reductions in HLBF and at 
maximal metaboreflex activation hindlimb resistance was significantly lower than 
control.  After induction of HF in the same animals, hindlimb resistance during free-flow 
exercise was significantly higher than in healthy subjects and HLBF was significantly 
lower (Table 4.1).  Hindlimb resistance decreased with initial reductions in  HLBF  and  
markedly  increased  in response  to metaboreflex  activation. 
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Hindlimb resistance at maximal metaboreflex activation was significantly higher 
than in healthy subjects.  Following α1-blockade in HF animals, hindlimb resistance 
during free-flow exercise was significantly lower and HLBF was markedly higher than 
during control experiment in HF animals.  Initial reductions in HLBF led to a decrease in 
hindlimb resistance, indicating vasodilation.  Following muscle metaboreflex activation, 
the large vasoconstriction observed in control experiments in HF was completely 
abolished.   
Figure 4.4 shows average slopes of the relationship between hindlimb vascular 
resistance and HLBF during control and α1-blockade experiments before and after 
induction of HF.  During control experiments in healthy subjects, the initial slope was 
significantly different from the pressor slope.  After α1-adrenergic blockade, the initial 
and pressor slopes were not significantly different from each other.  The initial slope 
after α1-blockade was similar to that in control while the pressor slope was reversed and 
Figure 4.3. Average hindlimb resistance responses during free-flow exercise,
metaboreflex threshold and maximal metaboreflex activation during control (open
circles) and α1-blockade (filled circles) experiments in normal (left panel) and heart
failure (right panel). *p<0.05 vs. previous setting in same experiment; † p<0.05 vs.
control; ‡ p<0.05 vs. normal. 
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significantly different from control.  After induction of HF, the initial and pressor slopes 
were significantly different from each other and markedly larger than in normal subjects.  
After α1-adrenergic blockade in HF animals, the two slopes were significantly different 
from each other and from the control experiments in HF.  
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Figure 4.4. Average initial and pressor slope values of hindlimb resistance during 
control (open bars) and α1-blockade (filled bars) experiments in normal (left panel) and 
heart failure (right panel) animals. *p<0.05 vs. initial slope; † p<0.05 vs. control; ‡ 
p<0.05 vs. normal.  
 
Table 1 shows mean hemodynamic data during rest, mild exercise and muscle 
metaboreflex activation in control and α1-blockade experiments in normal and HF 
animals.  From rest to exercise in control, there were significant increases in MAP, CO, 
HR, NIVC, HLBF and ventricular contractility.  With muscle metaboreflex activation, 
there were further significant increases in MAP, CO, HR, NIVC, and indices of 
ventricular inotropic and lusitropic state.  Following α1-adrenergic blockade in normal 
animals, resting MAP was significantly lower while NIVC and contractility were 
significantly higher than in control.  With mild dynamic exercise there was a significant 
increase in all variables and MAP, CO, NIVC, and dP/dtmax were markedly higher than 
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control exercise levels.  Muscle metaboreflex activation following α1-blockade resulted 
in substantial increases in MAP, CO, HR, NIVC dP/dtmax and dP/dtmin.  The reflex-
induced pressor response following α1-blockade was significantly attenuated compared 
to control while CO, NIVC and ventricular contractility during maximal metaboreflex 
activation was substantially higher that during control.  
Table 4.1. Mean hemodynamic values during rest, mild exercise (EX) and muscle 
metaboreflex activation (MMA) before and after α1-blockade in normal and heart failure 
animals. 
NORMAL HEART FAILURE 
    Control α1-blockade   Control α1-blockade 
MAP Rest 89.1±1.8 80.9±1.5 † 77.0±0.6 ‡ 71.1±1.6  
(mmHg) Ex 91.5±1.9 * 83.8±1.4 *† 79.6±2.0 ‡ 72.3±1.0 
  MMA 142.6±1.5 * 117.5±2.4 *† 111.2±3.8 ‡ 105.3±3.8  
CO Rest 2.78±0.16 2.96±0.21 2.26±0.11 ‡ 2.53±0.13 † 
(l/min) Ex 4.31±0.22 * 4.48±0.22 *† 3.38±0.14 *‡ 4.00±0.17 *† 
  MMA 6.16±0.13 * 6.37±0.19 *† 3.84±0.22 ‡ 5.57±0.17 *† 
HR Rest 75.2±4.1 89.8±5.3  105.0±5.8 102.0±4.0 
(bpm) Ex 105.4±3.4 * 119.6±3.4 * 137.2±5.8 * 139.6±6.0 * 
  MMA 140.3±3.2 * 159.9±10.1 * 165.5±6.6 * 173.6±5.0 *† 
NIVC Rest 24.9±1.7 29.5±2.4 † 24.5±1.6 29.2±2.1 † 
(ml/min/mmHg) Ex 35.4±2.2 * 40.6±2.6 *† 33.1±1.3 * 41.0±2.6 *† 
  MMA 40.2±1.2 * 49.6±1.7 *† 29.9±1.2 *‡ 48.0±2.2 *† 
HLBF Rest 0.57±0.05 0.58±0.04 0.40±0.02 ‡ 0.49±0.02 † 
(l/min) Ex 1.06±0.05 * 1.08±0.07 * 0.85±0.05 *‡ 1.03±0.08 *† 
  MMA 0.54±0.05 * 0.58±0.07 * 0.48±0.04 *‡ 0.57±0.06 *† 
dP/dtmax Rest 1854±61 1827±69 † 792±20 ‡ 882±39 
(mmHg/s) Ex 2030±93 * 2120±71 *† 911±57 *‡ 1064±53 * 
   MMA 2892±104 * 3211±145 *† 1266±24 *‡ 1640±136 *† 
dP/dtmin Rest  -1593±83 -1435±42 -786±31 ‡ -882±56 
(mmHg/s) Ex  -1653±84 -1513±30 * -863±52 ‡ -1033±32 † 
   MMA  -2585±89 * -2219±128 * -1200±9 *‡ -1521±89 *† 
Values are means ± SE. MAP, mean arterial pressure; CO, cardiac output; HR, heart rate; NIVC, non-
ischemic vascular conductance; HLBF, hindlimb blood flow; dP/dtmax, maximal rate of left ventricular 
pressure increase; dP/dtmin maximal rate of left ventricular relaxation. *p<0.05 vs. previous setting in same 
experiment; † p<0.05 vs. control; ‡ p<0.05 vs. normal.  
After induction of HF in the same animals, resting levels of MAP, CO, HLBF, 
dP/dtmax and dP/dtmin were significantly lower.  Although CO, HR, NIVC, HLBF and 
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ventricular contractility increased from rest to exercise, they were significantly lower 
than normal exercising levels with the exception of HR.  Following metaboreflex 
activation in HF animals, increases in MAP, CO, dP/dtmax and dP/dtmin were significantly 
attenuated and there was vasoconstriction in the non-ischemic vasculature.  Following 
α1-adrenergic blockade, resting CO, HLBF and NIVC increased.  From rest to exercise, 
significant increases in CO, HR, NIVC, HLBF and ventricular contractility were 
observed.  Muscle metaboreflex activation following α1-blockade in HF animals 
significantly increased CO, HR, NIVC, dP/dtmax and dP/dtmin and these parameters were 
significantly improved compared to metaboreflex responses in HF.  
Discussion 
The major new finding of this study is that muscle metaboreflex-induced 
vasoconstriction of the ischemic active skeletal muscle is exaggerated in heart failure.  
Previous studies have shown that metaboreflex-induced increase in MAP partially 
restores blood flow to ischemic active muscle in healthy subjects.  Whether the muscle 
metaboreflex-induced increase in sympathetic activity causes vasoconstriction the 
ischemic active muscle has been controversial (33, 54, 59).  We recently showed that 
metaboreflex activation during submaximal exercise induces α-mediated sympathetic 
vasoconstriction within the ischemic active muscle, limiting the capability of 
metaboreflex to restore blood flow to the muscle (36).  In HF, the ability of the reflex to 
increase CO is markedly limited and the metaboreflex-induced pressor response occurs 
primarily via peripheral vasoconstriction. Inability to increase CO in HF limits restoration 
of blood flow to the ischemic muscle and exaggerated vasoconstriction of ischemic 
active muscle would further limit blood supply and enhance muscle ischemia.  This 
generates a positive feedback loop that potentially contributes to exercise intolerance in 
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HF.  
Metaboreflex responses in HF 
Inasmuch as heightened coronary vasoconstriction limits the cardiac function 
(15) and little increase in CO occurs in HF, mechanisms of muscle metaboreflex shift 
from CO-mediated to peripheral vasoconstriction induced pressor response (16, 29, 58).  
The limited CO increase in HF attenuates the rise in MAP and consequently, limits the 
ability of metaboreflex to partially restore blood flow to the ischemic muscle.  
Vasoconstriction of inactive beds plays a very small role in generating the pressor 
response as blood flow to inactive beds constitutes only a small proportion of CO and 
thereby, total vascular conductance (52).  With active skeletal muscle comprising the 
largest fraction of total vascular conductance, it is the only target vasculature for 
vasoconstriction during metaboreflex activation capable of generating large pressor 
responses.  This is the first study to show that metaboreflex-induced hindlimb 
vasoconstriction is exaggerated in HF.  The vasoconstriction is abolished after α1-
blockade, indicating the sympathetic origin of the vasoconstriction.  In addition, α1-
blockade also markedly improved HLBF during free-flow exercise, revealing a potential 
therapeutic target for exercise intolerance in HF.  
If muscle metaboreflex activation induces sympathetically-mediated constriction 
of the ischemic muscle from which it originates, active ischemic muscle is both the 
origin and the target of the reflex.  On the afferent side, metabolic accumulation in the 
muscle stimulates group III/IV nerves and elicits the muscle metaboreflex which in turn 
increases CO, redistributes blood flow and causes vasoconstriction of the ischemic 
muscle on the efferent side.  Vasoconstriction of the already ischemic muscle would 
further limit the oxygen delivery to the muscle causing more ischemia and heightened 
51 
 
metaboreflex activation.  We previously showed that in normal subjects, metaboreflex-
induced vasoconstriction of the ischemic active muscle acts as a limiting positive 
feedback where afferent and efferent responses progressively become smaller and 
plateau at an amplified response level (36).  The slope of the relationship between 
hindlimb resistance and HLBF in normal animals is -32.6 units compared to -97.9 units 
after induction of HF.  The slope value indicates that for every liter/min decrease in 
HLBF, there is a 97.9 unit increase in hindlimb resistance.  At the threshold level of 
HLBF, a 97.9 mmHg/l/min increase in hindlimb resistance would cause 0.84 l/min fall in 
HLBF if pressure remained constant.  This decrease in HLBF would cause further 
ischemia and increase hindlimb resistance by 82.1 mmHg/l/min, which in turn would 
reduce HLBF by 0.2 l/min and so forth.  Thus, the stimulus and the response become 
smaller with each cycle of positive feedback and will eventually reach a plateau.  
Therefore, muscle metaboreflex activation in HF is still a limiting positive feedback reflex 
albeit with a markedly amplified slope than in normal subjects.  Previous studies have 
shown a larger vasoconstriction of the peripheral vasculature with heavier workloads (6, 
30).  With increase in workload, the metaboreflex could easily convert into a run-away 
feedback loop where the stimulus and the response get larger with each cycle, rapidly 
reaching infinite resistance.  Indeed, the large vasoconstriction we observed in HF is 
perilously close to a level in which the increase in resistance would elicit a fall in flow 
greater than that which engaged the reflex.  The result would be a rapidly escalating 
response leading to total vasoconstriction.  
Mechanisms for heightened SNA in HF 
Heightened SNA and impaired muscle blood flow in HF could result from various 
different pathways and vascular factors.  The arterial baroreflex buffers about one-half 
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of the metaboreflex-induced pressor response in normal animals by restraining 
peripheral vasoconstriction (40).  In HF, the strength of baroreflex is impaired at both 
rest (61) and during exercise (38).  The reduced baroreflex buffering of the metaboreflex 
potentially contributes to elevated SNA and peripheral vasoconstriction in HF. 
Respiratory muscles play an important role in muscle metaboreflex activation during 
dynamic exercise (64).  Low CO in HF causes hypoperfusion of all tissues including 
respiratory muscles. Increased exertion of the respiratory muscles during exercise in HF 
likely causes enhanced afferent activation augmenting the metaboreflex-induced 
responses.  A recent study also implicated aberrant activation of cardiac sympathetic 
afferents in HF which contributes to elevated SNA at rest (92).  Enhanced arterial 
chemoreflex activation has also been shown in HF  (83).  Neurogenic vasoconstriction 
of the active skeletal muscle is attenuated by the metabolic by-products in the muscle, 
termed functional sympatholysis (63).  However, functional sympatholysis is impaired in 
pathophysiological states such as HF, hypertension, etc. (85, 90).  Moreover, impaired 
endothelium-mediated vasodilation and elevated circulating levels of catecholamines, 
vasopressin, angiotensin II, etc. could further increase the peripheral vasoconstriction in 
HF subjects (22, 30).  Some studies have shown reduced oxidative type I fibers and 
increased glycolytic type II b fibers in HF subjects which could reduce their exercise 
capacity and lead to exercise intolerance (23, 82). 
Perspectives 
The muscle metaboreflex is not tonically active at mild workload in canines as 
HLBF must be reduced below threshold flow before any metaboreflex responses are 
observed.  Due to lower perfusion in HF, metaboreflex threshold during mild exercise is 
achieved earlier and likely contributes to heightened vasoconstriction with metaboreflex 
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activation in HF as workload increase and tonic activity of the reflex ensues. (6).  To 
what extent the muscle metaboreflex approaches run-away positive feedback levels 
with higher intensity exercise is unknown.  Furthermore, there is evidence that reflexes 
arising from skeletal muscle afferents are tonically active in humans during even 
relatively mild exercise (2, 68).  The exaggerated vasoconstriction within the ischemic 
active muscle together with limited metaboreflex restoration of the blood flow to the 
ischemic muscle likely impairs the ability to exercise and contributes to exercise 
intolerance in HF. 
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CHAPTER 5 - MUSCLE METABOREFLEX AND ARTERIAL BAROREFLEX: ACTION, 
INTERACTION AND CONTROL OF BLOOD FLOW TO ACTIVE MUSCLE  
Abstract  
The muscle metaboreflex and arterial baroreflex regulate arterial pressure 
through distinct mechanisms.  Muscle metaboreflex activation (MMA) elicits a pressor 
response virtually solely by increasing cardiac output (CO) while baroreceptor unloading 
increases mean arterial pressure (MAP) primarily through peripheral vasoconstriction.  
We activated the muscle metaboreflex in chronically instrumented canines during 
dynamic exercise (via graded reductions in hindlimb blood flow; HLBF) followed by 
simultaneous baroreceptor unloading (via bilateral carotid occlusion; BCO).  We 
hypothesized that simultaneous activation of both reflexes would result in an 
exacerbated pressor response owing to both an increase in CO and vasoconstriction.  
We observed that MMA caused a significant increase in MAP, heart rate (HR), CO, and 
non-ischemic vascular conductance (NIVC; conductance of all vascular beds except the 
hindlimb vasculature).  When followed by BCO during MMA, there were further 
increases in MAP and HR however, NIVC decreased by ~25% indicating substantial 
peripheral vasoconstriction.  Although there was significant vasoconstriction within the 
ischemic muscle itself, the remaining vasculature vasoconstricted to a greater extent, 
thereby redirecting blood flow to the ischemic muscle.  We conclude that baroreceptor 
unloading during MMA induces preferential peripheral vasoconstriction to improve blood 
flow to the ischemic active skeletal muscle.  
Introduction 
Insufficient oxygen delivery to the active skeletal muscle during exercise causes 
accumulation of metabolites (e.g., hydrogen ions, adenosine, lactic acid, etc.) which 
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stimulate the group III and IV muscle afferents eliciting a reflex pressor response, 
termed the muscle metaboreflex (1, 9, 35, 43, 65, 77).  Muscle metaboreflex activation 
during dynamic exercise significantly increases mean arterial pressure (MAP), cardiac 
output (CO), heart rate (HR) and ventricular contractility which combined with enhanced 
right atrial pressure maintains or slightly increases stroke volume (16, 32, 70, 71, 78, 
88, 95).  Although some regional vasoconstriction occurs with metaboreflex activation 
during submaximal exercise (e.g., coronary, renal, forelimbs (3, 6, 13, 48, 49)), total 
vascular conductance (TVC) is relatively unchanged (6, 17, 18, 29, 74).  Thus, muscle 
metaboreflex-induced pressor response during dynamic exercise occurs virtually solely 
due to an increase in CO (6, 29, 55, 71, 78, 95).   
At rest and during exercise the arterial baroreflex is the primary short-term 
negative feedback reflex which maintains arterial pressure by regulating TVC and CO.  
The arterial baroreflex primarily modulates TVC as little change in CO occurs during 
steady state (11, 60, 79, 80, 91).  Therefore, the muscle metaboreflex and the arterial 
baroreflex regulate arterial pressure via two distinct mechanisms.  Muscle metaboreflex 
activation increases MAP primarily by increasing CO whereas arterial baroreflex 
activation increases MAP primarily through peripheral vasoconstriction.  As workload 
increases, active skeletal muscle vasculature becomes an increasingly important target 
for baroreflex-induced peripheral vasoconstriction (11).  We recently showed that 
muscle metaboreflex activation induces sympathetic vasoconstriction within the 
ischemic muscle thereby limiting the ability of the metaboreflex to improve muscle blood 
flow (36).  The interaction of the muscle metaboreflex and the arterial baroreflex has not 
been well established, especially when these reflexes are coactivated. In this study, we 
quantified the contribution of CO and TVC to the pressor response elicited by carotid 
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baroreceptor unloading (via bilateral carotid occlusion; BCO) at rest, during mild 
exercise and during muscle metaboreflex activation.  We investigated whether 
concurrent activation of the two reflexes undergoes an additive, occlusive or facilitative 
interaction.  Since carotid baroreceptor unloading induces peripheral vasoconstriction, 
to what extent the ischemic muscle vasoconstricts during concurrent activation of the 
baroreflex and the muscle metaboreflex is unknown.  Previous studies hypothesized 
that increases in metabolic by-products in skeletal muscle during exercise reduces the 
efficacy of sympathetic nerves to elicit vasoconstriction (63, 84).  We hypothesized that 
baroreceptor unloading during metaboreflex activation would still elicit substantial 
systemic peripheral vasoconstriction even within the ischemic hindlimb.  However, if 
non-ischemic beds are more susceptible to neurogenic vasoconstriction, then there may 
be redistribution of the available CO towards the ischemic muscle.    
Methods 
Experimental subjects 
Eight adult mongrel canines (5 females, 3 males; 20-25 kg) were selected for the 
study.  All the procedures were approved by the Institutional Animal Care and Use 
Committee (IACUC) of Wayne State University and complied with the National Institutes 
of Health Guide to the Care and Use of Laboratory Animals.  All animals were 
acclimatized to the laboratory surroundings and willing to run on a motor-driven 
treadmill; no negative reinforcement techniques were utilized. 
Surgical procedures 
For each of the three surgical procedures, the animals were sedated with 
acepromazine (0.2-0.5 mg/kg IM) and received preoperative analgesics [carprofen (4.4 
mg/kg IV), buprenorphine (0.01-0.03 mg/kg IM) and fentanyl (50–125 µg/h (72h) 
57 
 
transdermal delivery)].  Anesthesia was induced with ketamine and diazepam (5 mg/kg 
IV and 0.2-0.3 mg/kg IV, respectively) and maintained with isoflurane gas (1–3%).  
Cefazolin (antibiotic, 30 mg/kg IV) was administered pre- and postoperatively to avoid 
acute postoperative infections.  Animals were closely monitored postoperatively and 
given buprenorphine (0.01-0.03 mg/kg IM) and acepromazine (0.2-0.3 mg/kg IV) as 
needed.  Cephalexin (antibiotic, 30 mg/kg (BID) PO) was administered prophylactically 
for the entire term of the experimental protocol.  The animals recovered for two weeks 
after each surgery. 
In the first surgical procedure, the thoracic cavity was opened via a left 
thoracotomy (3rd/4th intercostal space) approach and the pericardium was cut to 
expose the heart.  A telemetry pressure transmitter (TA11 PA-D70, DSI) was tethered 
subcutaneously at the height of the left ventricular apex and two intercostal spaces 
caudal to the thoracotomy incision (n=5).  The tip of the pressure transducer catheter 
was inserted into the left ventricle and secured.  A perivascular flow probe (20PAU, 
Transonic Systems) was placed around the ascending aorta to measure CO.  Pacing 
wires were secured to the free wall of the right ventricle for studies unrelated to the 
present study.  The pericardium was reapproximated and all wires were tunneled 
subcutaneously and exteriorized between the scapulae.  The chest was closed in 
layers.  
In the second surgical procedure, the abdominal aorta and left renal artery were 
exposed through a left retroperitoneal approach.  Perivascular flow probes (Transonic 
Systems) were positioned around the terminal aorta (10PAU) and the left renal artery 
(4PSB) to measure hindlimb blood flow (HLBF) and renal blood flow (RBF), 
respectively.  All side branches of the terminal aorta between the iliac arteries and the 
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aortic flow probe were ligated and severed.  Two hydraulic occluders (8-10 mm, DocXS 
Biomedical Products) were placed around the terminal aorta distal to the flow probe.  A 
19-gauge polyvinyl catheter (Tygon, S54-HL, Norton) was inserted into a side branch of 
the aorta cranial to the flow probe to measure systemic arterial pressure.  A second 
catheter was inserted into a side branch of the aorta caudal to the occluders to measure 
arterial pressure below the occluders (femoral arterial pressure; FAP).  When the 
catheterization of a caudal aortic branch was not possible, a side branch of the femoral 
artery was catheterized in the third procedure.  All instrumentation was tunneled 
subcutaneously and exteriorized between the scapulae and the abdomen was closed in 
layers.  
In the third surgical procedure, a hydraulic occluder (4-6 mm, DocXS Biomedical 
Products) was placed around each common carotid artery via a midline neck incision in 
order to perform bilateral carotid occlusion (BCO).  The right jugular vein was 
catheterized (n=3) for studies unrelated to the present study. Instrumentation was 
tunneled subcutaneously and exteriorized between the scapulae and the neck was 
closed in layers.  
Data acquisition 
Before each experiment, animals were brought into the laboratory and allowed to 
roam freely and acclimate for ~10-20 minutes, before being directed onto the treadmill.  
The CO, RBF, and HLBF flow probe cables were connected to flow meters (TS420, 
Transonic Systems) and the left ventricular implant transmitter was turned on to collect 
data via telemetry (DSI).  The arterial catheters were aspirated, flushed and connected 
to pressure transducers (Transpac IV, ICU Medical).  All hemodynamic variables, in 
addition to MAP (calculated) and HR (triggered by the CO signal), were monitored as 
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real-time waveforms by a data acquisition system (LabScribe, iWorx) and recorded for 
subsequent off-line analysis.  
Experimental procedures 
All experiments were performed after the animals had fully recovered from 
surgery (i.e., were active and of good appetite).  Each experiment began with the animal 
standing still on the treadmill until all resting hemodynamic data were observed to be 
stable (~ 5-10 min).  Three different experimental protocols were used: BCO at rest, 
BCO during exercise and BCO with muscle metaboreflex activation.  In the first 
experimental protocol, steady state data collection at rest was followed by BCO 
performed by inflating the carotid occluders for 2 min while the animals were standing 
on the treadmill.  BCO during exercise: After collecting resting steady state data, the 
treadmill was turned on and gradually increased to a speed of 3.2 kph at 0% grade (mild 
exercise).  The animals exercised for 5-10 min followed by BCO for 2 min during the 
same workload.  BCO during metaboreflex activation:  After collecting steady state data 
during rest and mild exercise, muscle metaboreflex was engaged via graded reductions 
in HLBF (via partial inflation of terminal aortic occluders) during mild exercise.  Each 
level of vascular occlusion was maintained until all parameters had reached steady 
state (~ 3-5 min).  After the steady state for maximal metaboreflex activation, BCO was 
performed for 2 min.  The large increase in MAP with BC during metaboreflex activation 
would force more flow through the hindlimb occluders which would lessen metaboreflex 
activation, therefore the occluder resistance was increased to keep HLBF constant. 
Data analysis 
MAP, FAP, CO, HR, RBF, left ventricular pressure and HLBF were continuously 
recorded during each experimental procedure.  Other hemodynamic parameters were 
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calculated during off-line data analysis (e.g., dP/dtmax, dP/dtmin, total vascular 
conductance (TVC), renal vascular conductance (RVC), hindlimb vascular conductance 
(HVC) and conductance of all vascular beds except the hindlimbs (non-ischemic 
vascular conductance; NIVC).  TVC, RVC, HVC and NIVC were calculated as CO/MAP, 
RBF/MAP, HLBF/FAP and (CO-HLBF)/MAP, respectively.  Due to technical difficulties, 
dP/dtmax and dP/dtmin values were only calculated in five animals.  One minute averages 
of all variables were taken during steady-state at rest, free-flow exercise, muscle 
metaboreflex activation and BCO.  Mean values were averaged across all animals to 
obtain the sample mean of the study.  
Partial reductions in HLBF by using the hydraulic occluders cause MAP to 
increase passively (MAPpassive) (6, 95).  Thus, the pressor response observed with 
metaboreflex activation in our experiments is a combination of a reflex increase in MAP 
(MAPactive) and the passive effect of the occluder.  MAPpassive was calculated as 
COEX/(NIVCEX + HVCObserved), where the subscript EX indicates free-flow exercise 
levels. MAPactive, the increase in MAP due to reflex activation, was calculated by 
subtracting MAPpassive from the observed MAP values.  
The percent contributions of CO and TVC to the baroreflex-induced pressor 
response were calculated as follows:  
∆ MAPTVC =         COPre                  _        COPre   
               NIVCBCO + HVCBCO             NIVCPre + HVCPre 
 
% contribution of TVC =    ∆ MAPTVC       x  100  
                                   ∆ MAPObserved 
 
∆ MAPCO =  (COBCO - COPre)   
                  NIVCPre + HVCPre 
 
% contribution of CO =    ∆ MAPCO      x  100    
                                ∆ MAPObserved     
where the subscripts BCO and Pre indicate BCO and pre-BCO levels, respectively.  
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Since all of the pressor response to BCO during muscle metaboreflex activation was 
due to peripheral vasoconstriction, the percent contribution of TVC was calculated as 
100 – percent contribution of CO.  BCO during metaboreflex activation causes a large 
pressor response which leads to an increase in HLBF which would in turn change the 
stimulus for muscle metaboreflex.  Thus, HLBF was kept constant by increasing the 
occluder resistance.  We calculated the predicted rise in HLBF, if there was no increase 
in occluder resistance, as (MAP during BCO)/(hindlimb resistance during BCO + 
occluder resistance during metaboreflex activation). 
Statistical analysis 
All hemodynamic data are reported as means ± SE. An α-level of P < 0.05 was 
used to determine statistical significance.  Paired t-tests were performed to compare the 
responses between rest and BCO during rest.  Averaged responses for each animal 
were analyzed with Systat software (Systat 11.0).  A one-way ANOVA with repeated 
measures was used to compare hemodynamic data for time effect.  In the event of a 
significant time effect, a C-matrix test for simple effects was performed. 
Results 
Figure 5.1 shows representative hemodynamic responses evoked by BCO during 
rest, mild exercise and muscle metaboreflex activation in one animal.  BCO at rest 
resulted in a large pressor response with little change in CO and a large decrease in 
NIVC, indicating that the pressor response was mediated predominately by peripheral 
vasoconstriction.  From rest to exercise, there was moderate increase in CO, NIVC and 
HLBF.  BCO during mild exercise increased MAP again predominately due to a large 
decrease in NIVC.  Small increases in CO and HLBF also occurred. With metaboreflex 
activation during mild exercise, the large pressor response is occurred via a large 
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increase in CO as there was a modest increase in NIVC.  Baroreceptor unloading 
during muscle metaboreflex activation caused a further large increase in MAP.  This 
pressor response was mediated via peripheral vasoconstriction inasmuch as a large 
decrease in NIVC as well as a small decrease in CO occurred.  In order to keep the 
metaboreflex stimulus constant during concurrent activation of baroreflex and 
metaboreflex, HLBF was maintained constant by manually increasing the resistance of 
the hydraulic occluders on the terminal aorta.  
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Figure 5.1. Data from one animal showing mean arterial pressure, cardiac output, non-
ischemic vascular conductance and hindlimb blood flow in response to bilateral carotid 
occlusion (BCO) during rest (left panel), exercise (Ex; middle panel) and muscle 
metaboreflex activation (MMA; right panel). 
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Figure 5.2. Average hemodynamic data during (A) rest (open bars) and bilateral carotid 
occlusion (BCO) at rest (grey bars); (B) rest, mild exercise (Ex; hatched bars) and BCO 
during Ex (grey bars); (C) rest, Ex, muscle metaboreflex activation (MMA; cross-
hatched bars) and BCO during MMA (solid bars). * p<0.05 vs. previous setting. 
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Figure 5.2 shows average values of MAP, CO, HR, NIVC, RVC, dP/dtmax and 
dP/dtmin during BCO at rest, during mild exercise and metaboreflex activation.  
BCO at rest.  Carotid baroreceptor unloading at rest resulted in a significant 
increase in MAP with small but significant increases in CO, HR, dP/dtmax and dP/dtmin.  
Large significant decreases in NIVC and RVC indicates that the pressor response was 
primarily caused by peripheral vasoconstriction. 
BCO during exercise.  From rest to exercise, there were a significant increases in 
NIVC, CO, HLBF, and HR.  BCO during exercise resulted in significant increases in 
MAP, CO, HR, dP/dtmax and dP/dtmin and significant decreases in NIVC and RVC.  
BCO during metaboreflex activation.  NIVC, CO, and HR increased significantly 
from rest to exercise.  Muscle metaboreflex activation (via partial reduction in HLBF) 
caused significant increases in MAP, NIVC, CO, HR, dP/dtmax and dP/dtmin while RVC 
decreased significantly.  Coactivation of baroreflex and muscle metaboreflex resulted in 
a further significant increases in MAP, HR, dP/dtmax and dP/dtmin and significant 
decreases in NIVC, CO and RVC. 
Figure 5.3 shows the hemodynamic changes in hindlimb vascular conductance 
and HLBF during BCO at rest, during mild exercise and muscle metaboreflex activation.  
During BCO at rest, HVC significantly decreased indicating vasoconstriction in the 
hindlimb vasculature.  HLBF increased despite the vasoconstriction due to the increase 
in MAP.  From rest to exercise, both HVC and HLBF increased significantly.  In 
response to BCO during exercise, there was a large decrease in HVC and HLBF again 
increased somewhat HLBF.  Muscle metaboreflex was activated during mild exercise by 
reducing HLBF to ~40% of the value observed during free-flow exercise.  We have 
recently shown that initial reductions in HLBF cause vasodilation in the hindlimb, but 
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when the metaboreflex is engaged, vasoconstriction ensues which brings HVC back 
towards the levels observed prior to hindlimb ischemia (37).  With BCO during muscle 
metaboreflex activation, there is a significant decrease in HVC indicating 
vasoconstriction.  The HLBF during the co-activation of both reflexes was kept constant 
by increasing the hindlimb occluder resistance.  If there was no change in the occluder 
resistance, HLBF would have increased significantly (predicted HLBF). 
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Figure 5.3. Average hindlimb vascular conductance and hindlimb blood flow responses 
during (A) rest (open bars) and bilateral carotid occlusion (BCO) at rest (grey bars); (B) 
rest, mild exercise (Ex; hatched bars) and BCO during Ex (grey bars); (C) rest, Ex, 
muscle metaboreflex activation (MMA; cross-hatched bars) and BCO during MMA (solid 
bars). The bar inscribed with P indicates the predicted HLBF during coactivation of two 
reflexes.* p<0.05 vs. previous setting. 
Figure 5.4 shows the absolute changes in the cardiovascular parameters evoked 
by BCO at rest, during mild exercise and during metaboreflex activation in eight normal 
animals.  The pressor responses evoked by BCO at rest, during exercise and during 
metaboreflex activation were not different from each other.  Changes in CO, HR, 
dP/dtmax, dP/dtmin, RVC and HLBF were similar during BCO at rest and BCO during mild 
exercise.  However,  decreases  in  NIVC  and  HVC  were significantly larger with BCO  
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Figure 5.4. The absolute changes (∆) in hemodynamic values from rest to bilateral
carotid occlusion (BCO) during rest (open bars), from exercise (Ex) to BCO during Ex
(hatched bars) and from muscle metaboreflex activation (MMA) to BCO during MMA
(filled bars). * p<0.05 vs. previous setting. MAP, mean arterial pressure; CO, cardiac
output; HR, heart rate; dP/dtmax, maximal rate of change in left ventricular pressure;
dP/dtmin, minimal rate of change in left ventricular pressure; RVC, renal vascular
conductance; NIVC, non-ischemic vascular conductance; HVC, hindlimb vascular
conductance; HLBF, hindlimb blood flow.  
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during exercise than BCO at rest.  With coactivation of baroreflex and metaboreflex, 
there was a large increase in HR with further improvement in contractility and lusitropy, 
however, CO decreased slightly.  While the vasoconstriction of non-ischemic vascular 
beds in response to coactivation of reflexes was similar to that during BCO with 
exercise, the reduction in RVC and HVC was significantly smaller than with BCO during 
exercise.  The predicted increase in HLBF during coactivation of reflexes was similar to 
the increase in HLBF seen in response to BCO during mild exercise. 
To investigate the mode of interaction between arterial baroreflex and muscle 
metaboreflex (i.e., additive, facilitative or occlusive interaction), the observed responses 
during coactivation of baroreflex and metaboreflex activation were compared to the sum 
of metaboreflex-induced and BCO-induced responses during exercise.  Figure 5.5 
shows absolute changes in hemodynamic parameters in response to BCO during 
exercise, muscle metaboreflex activation, the sum of muscle metaboreflex-induced and 
BCO-induced responses during exercise and the observed hemodynamic changes in 
response to BCO during metaboreflex activation.  The sum of individual reflex 
responses and the observed responses during coactivation were not different for MAP, 
NIVC and ventricular function, indicating an additive interaction.  However, the observed 
responses during coactivation of the two reflexes were smaller for CO and RVC 
indicating that for these parameters the arterial baroreflex and the muscle metaboreflex 
summate as occlusive interaction.  On the contrary, coactivation responses were 
significantly higher than the sum of individual responses for HR, indicating a facilitative 
interaction. 
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Figure 5.5. Absolute changes (∆) in cardiovascular responses evoked by bilateral 
carotid occlusion (BCO) during mild exercise (hatched bars), muscle metaboreflex 
activation (MMA; cross-hatched bars), sum of individual MMA and BCO responses 
during exercise (SUM; filled bars) and observed combined effect of the MMA and BCO 
during MMA (OBS; open bars). ‡ p<0.05 vs. calculated sum of reflex-induced response 
during MMA and BCO during exercise.  
Figure 5.6 shows the relative contribution of CO and TVC in mediating the rise in 
MAP in response to BCO during rest, BCO during exercise, muscle metaboreflex 
activation and BCO during metaboreflex activation.  Pressor response to BCO during 
rest and exercise was primarily due to peripheral vasoconstriction as there is only a 
small contribution of CO.  Muscle metaboreflex-induced pressor response was virtually 
solely driven by increase in CO as there is negative contribution of TVC.  Pressor 
response with BCO during metaboreflex activation was solely due to the increase in 
peripheral vasoconstriction.  
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Figure 5.6. Percent contribution of cardiac output (CO; open bars) and total vascular 
conductance (TVC; filled bars) to pressor response evoked by bilateral carotid occlusion 
(BCO) at rest, BCO during exercise, muscle metaboreflex activation (MMA) and BCO 
during MMA. * p<0.05 vs. contribution of CO. 
Discussion 
This is the first study to investigate the strength and mechanisms of the muscle 
metaboreflex and arterial baroreflex when activated separately and concurrently, and 
the effect of this interaction on ventricular function, cardiac output and the distribution of 
total systemic peripheral blood flow.  We found that the pressor responses to 
baroreceptor unloading and metaboreflex activation were additive, however the 
mechanisms mediating each pressor response were diametrically opposite: arterial 
baroreflex activation primarily induces peripheral vasoconstriction whereas 
metaboreflex activation primarily raises CO.  When activated concurrently, profound 
pressor responses occur due to substantial vasoconstriction coupled with increased 
CO.  Further, we found that baroreceptor unloading during metaboreflex activation 
causes vasoconstriction even within the ischemic active skeletal muscle.  However, the 
vasoconstriction in all other vascular beds combined is greater than that in the ischemic 
muscle which thereby causes redistribution of cardiac output towards the ischemic 
beds.  This shift of total systemic blood flow towards the ischemic muscle during 
combined baroreflex and metaboreflex activation acts to attenuate the level of 
metaboreflex stimulation.   
70 
 
Muscle metaboreflex and arterial baroreflex interaction 
Reflexes interact in three different ways: additive interaction, where the 
coactivation responses equal the sum of reflex responses when activated individually; 
facilitative interaction, where responses during coactivation of two reflexes are larger 
than the sum of individual reflex responses; occlusive interaction, where the 
coactivation responses are smaller than the sum of individual reflex responses.  We 
observed that the pressor response evoked by BCO during metaboreflex activation was 
similar to the sum of metaboreflex-induced and BCO-induced pressor response during 
exercise, indicating additive interaction between the two reflexes.  The same conclusion 
holds for ventricular function and NIVC responses. However, CO and RVC responses 
exhibit occlusive interaction and HR responses undergo facilitative interaction upon 
coactivation of the two reflexes.  Therefore, the interaction between arterial baroreflex 
and muscle metaboreflex when activated simultaneously is intimately dependent on the 
hemodynamic parameter being investigated.  
Regulation of skeletal muscle blood flow 
During progressive dynamic exercise the skeletal muscle vasculature becomes 
an increasingly important target vascular bed mediating the rise in arterial pressure 
during in response to baroreceptor unloading (11, 60).  We recently showed that muscle 
metaboreflex activation induces sympathetic vasoconstriction within ischemic active 
muscle thereby, limiting the ability of the metaboreflex to improve muscle blood flow 
(36).  BCO during metaboreflex activation causes further vasoconstriction within the 
ischemic hindlimb vasculature, although the decrease in HVC during coactivation of two 
reflexes is significantly smaller than that observed in response to BCO during normal 
exercise.  One of the plausible causes for this smaller vasoconstriction in the hindlimb 
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vasculature could be functional sympatholysis, a phenomenon described as attenuated 
sympathetic vasoconstriction of the active skeletal muscle due to metabolic 
accumulation in the muscle (63, 84).  The large increase in MAP in response to BCO 
during metaboreflex activation increases HLBF despite the vasoconstriction of hindlimb 
vasculature.  Therefore, in order to maintain the same metaboreflex stimulus during 
coactivation of the reflexes, HLBF was kept constant by increasing the occluder 
resistance.  If there was no change in the occluder resistance, the HLBF (predicted 
HLBF) would have increased significantly with the rise in arterial pressure driving more 
flow through the occluder resistance as well as the hindlimb vascular resistance.  With a 
decrease in CO and vasoconstriction in the hindlimb vasculature during coactivation of 
the reflexes, the only way HLBF could have increased is by a larger vasoconstriction of 
the non-ischemic vasculature than the ischemic hindlimb vasculature.  This preferential 
vasoconstriction in the non-ischemic vasculature redirects blood flow to the hindlimbs 
which thereby increases HLBF.  This rise in HLBF would act to actually attenuate the 
metaboreflex activation.  Interestingly, we calculated that the predicted HLBF during 
coactivation of the two reflexes would have virtually restored HLBF almost back to the 
metaboreflex threshold level of 
HLBF (Figure 5.7). 
 
Figure 5.7. Mean arterial 
pressure and hindlimb blood flow 
during muscle metaboreflex 
activation (MMA; filled circles) 
followed by bilateral carotid 
occlusion (BCO) during MMA 
(open circles) in an experiment. 
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Where does vasoconstriction occur?  
Previous studies have shown that active skeletal muscle becomes the primary 
target bed for baroreflex-induced peripheral vasoconstriction with increasing exercise 
intensity (11).  We observed that although BCO during metaboreflex activation caused 
vasoconstriction within ischemic active muscle, blood flow to the ischemic muscle would 
still have improved (given that occluder resistance was not changed) due to a larger 
vasoconstriction in other vascular beds.  Since active skeletal muscle constitutes the 
largest proportion of TVC during exercise, the preferential vasoconstriction during 
coactivation of reflexes most likely occurs in active skeletal muscle other than the 
hindlimb.  Although there is some vasoconstriction of inactive beds such as renal 
vasculature during coactivation of baroreflex and muscle metaboreflex, inactive beds do 
not have much potential to increase MAP or redirect blood flow to other vasculatures 
(11, 52).  In the present study, the RVC responses underwent occlusive interaction 
upon coactivation of baroreflex and muscle metaboreflex.   
Perspectives and significance 
In normal individuals, metaboreflex activation causes large increases in CO and 
MAP which in turn increase blood flow and oxygen delivery to the active vascular beds. 
The arterial baroreflex buffers the metaboreflex pressor response by about 50% by 
attenuating peripheral vasoconstriction (40).  In conditions such as heart failure, where 
increases in CO become limited, the only mechanism to increase MAP is via peripheral 
vasoconstriction.  Inasmuch as the strength of arterial baroreflex is impaired in heart 
failure (38, 61), this would lessen the ability of arterial baroreflex to attenuate peripheral 
vasoconstriction induced by metaboreflex activation, leading to markedly large 
increases in vascular sympathetic tone, particularly the active ischemic muscle.  
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Moreover, baroreceptor unloading during metaboreflex activation leads to larger 
vasoconstriction of the non-ischemic vasculature causing improvement in HLBF.  In 
heart failure, this increase in HLBF could be attenuated, abolished, or possibly even 
reduce HLBF which could elicit a rampant positive feedback spiral where the baroreflex 
further engages the metaboreflex leading to a veritable sympathetic storm.  It is 
unknown whether these interactions contribute to the often massive peripheral 
vasoconstriction which occurs during exercise in heart failure and likely contribute to 
exercise intolerance in these patients. 
  
74 
 
CHAPTER 6 - INTERACTION BETWEEN ARTERIAL BAROREFLEX AND MUSCLE 
METABOREFLEX IS ALTERED IN HEART FAILURE 
Abstract 
Previous studies have shown that heart failure (HF) alters the strength and 
mechanisms of muscle metaboreflex and arterial baroreflex during dynamic exercise.  
Muscle metaboreflex activation (MMA) in normal individuals increases mean arterial 
pressure (MAP) virtually solely by an increase in cardiac output (CO) whereas in HF, 
metaboreflex-induced pressor response occurs via peripheral vasoconstriction.  The 
pressor response evoked by baroreceptor unloading in normal subjects occurs primarily 
through peripheral vasoconstriction and this pressor response is blunted in HF.  
However, the interaction between the two reflexes when activated simultaneously 
during dynamic exercise in HF is unknown.  We activated the muscle metaboreflex in 
chronically instrumented canines during mild exercise (via graded reductions in hindlimb 
blood flow; HLBF) followed by baroreceptor unloading (via bilateral carotid occlusion; 
BCO) before and after induction of HF.  We hypothesized that coactivation of both 
reflexes in HF would cause a smaller increase in MAP and a larger vasoconstriction of 
the ischemic hindlimb vasculature which would result in attenuated restoration of blood 
flow to the ischemic muscle observed in normal.  We observed that BCO during MMA 
increases MAP by substantial vasoconstriction of all vascular beds including the 
ischemic active muscle.  All cardiovascular responses with the exception of ventricular 
function exhibit occlusive interaction in response to baroreceptor unloading during MMA 
in HF.  We conclude that vasoconstriction of ischemic active skeletal muscle during 
coactivation of both reflexes attenuates the restoration of HLBF.  
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Introduction 
Stimulation of skeletal muscle afferents by metabolites, such as hydrogen ions, 
lactic acid, diprotonated phosphate, etc., that accumulate in the exercising muscle elicits 
a large pressor response, termed the muscle metaboreflex (1, 9, 35, 65, 77).  Muscle 
metaboreflex activation significantly increases mean arterial pressure (MAP), cardiac 
output (CO), heart rate (HR), ventricular contractility and right atrial pressure (16, 32, 
43, 70, 71, 88, 95).  During submaximal exercise, muscle metaboreflex-induced 
increase in MAP occurs virtually solely due to an increase in CO as there is little, if any, 
peripheral vasoconstriction (6, 17, 18, 29, 71, 74, 78).  Another blood pressure 
regulating reflex is the arterial baroreflex, a negative feedback reflex that maintains 
arterial pressure primarily by modulating peripheral vascular tone (11, 60, 79, 80, 91).  
Thus, the muscle metaboreflex and the arterial baroreflex regulate arterial pressure via 
two distinct mechanisms; muscle metaboreflex activation has a stronger control over 
cardiac sympathetic activity and increases MAP by increasing CO whereas arterial 
baroreflex activation has a stronger control over peripheral sympathetic activity and 
increases MAP primarily through peripheral vasoconstriction.  
In heart failure (HF), the strength and mechanisms of both muscle metaboreflex 
and arterial baroreflex are altered (29, 38, 39, 51, 81).  Impaired baroreflex sensitivity in 
HF results in a smaller increase in MAP in response to carotid hypotension at rest (61, 
93, 94) and during exercise (38, 39).  With limited CO reserve in HF, muscle 
metaboreflex activation elicits a pressor response primarily via peripheral 
vasoconstriction (14, 16, 29).  In normal subjects, baroreceptor unloading during muscle 
metaboreflex activation showed diverse interactions between different variables; MAP, 
NIVC and ventricular function were additive; CO and RVC were occlusive and HR 
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responses were facilitative.  Moreover, a larger preferential vasoconstriction of the non-
ischemic vascular beds redirected blood flow to the ischemic muscle increasing HLBF.  
In this study we investigate whether the interaction between the two reflexes when 
activated simultaneously is altered in HF.  We further studied the effect of coactivation 
of reflexes on ischemic active muscle in HF and whether there is any restoration of 
blood flow to the ischemic muscle.  
Methods 
Experimental subjects 
All procedures were approved by the Institutional Animal Care and Use 
Committee (IACUC) of Wayne State University and complied with the National Institutes 
of Health Guide to the Care and Use of Laboratory Animals.  Five adult mongrel canines 
(20-25 kg; 1 male, 4 females) were selected for the study.  The animals were 
acclimatized to the laboratory surroundings and exercised voluntarily during 
experimentation; no negative reinforcement techniques were utilized. 
Surgical procedures 
The surgical procedures and medications used have been previously described 
(36).  Briefly, a 20-mm flow transducer was placed around the aortic root to measure 
cardiac output (CO).  A telemetry pressure transmitter was tethered subcutaneously and 
its tip was inserted into the left ventricle to measure left ventricular pressure.  3-4 
stainless steel pacing wires (0-Flexon) were secured to the right ventricular free wall.  
Blood flow transducers was placed around the terminal aorta and the left renal artery to 
measure hindlimb blood flow (HLBF) and renal blood flow (RBF), respectively.  Two 
hydraulic occluders were placed around the terminal aorta distal to the flow probe to 
reduce HLBF.  Arterial catheters were placed to measure systemic arterial pressure and 
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femoral arterial pressure (FAP).  Hydraulic occluders were also placed around common 
carotid arteries to perform bilateral carotid occlusion (BCO).  The animals recovered for 
at least two weeks after each surgery.  
Data acquisition 
Before each experiment, the animals acclimated to the laboratory for ~10-20 
minutes, following which they were directed onto the treadmill.  The arterial catheters 
were aspirated, flushed and connected to pressure transducers (Transpac IV, ICU 
Medical), the flow probe cables were connected to flow meters (TS420, Transonic 
Systems) and the left ventricular telemetry implant was turned on.  All hemodynamic 
variables were monitored as real-time waveforms by LabScribe2 data acquisition 
system (iWorx) and recorded for off-line analysis.  
Experimental procedures 
Three different experimental protocols were used: BCO at rest, BCO during 
exercise and BCO during muscle metaboreflex activation.  BCO at rest: Steady state 
data at rest were collected while the animal stood still on the treadmill.  This was 
followed by BCO performed by inflating the carotid occluders for 2 minutes. BCO during 
exercise: After collecting resting steady state data, the treadmill speed was gradually 
increased to 3.2 kph at 0% grade (mild exercise).  The animals exercised until all 
hemodynamic data were stable (~5-10 minutes) followed by BCO for 2 minutes during 
the same workload. BCO during muscle metaboreflex activation: After collecting steady 
state data at rest and during mild exercise, HLBF was gradually reduced to ~40% of 
free-flow exercising levels (via partial inflations of the terminal aortic occluders) to 
activate the muscle metaboreflex.  Once steady state for muscle metaboreflex activation 
was achieved and data were recorded, BCO was performed for 2 minutes.  The large 
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increase in MAP with BCO during metaboreflex activation caused an increase in HLBF 
which in turn alters the metaboreflex stimulus.  Thus, HLBF was kept constant by 
increasing the occluder resistance.  After completion of experiments in normal animals, 
rapid ventricular pacing at the rate of 220-240 beats/min was used to induce HF in the 
same animals.  All three experimental protocols were repeated in HF. 
Data analysis 
MAP, FAP, CO, HLBF, RBF, heart rate (HR; triggered from CO signal) and left 
ventricular pressure (LVP) were continuously recorded during each experiment. Other 
hemodynamic parameters were calculated during off-line data analysis (e.g., dP/dtmax, 
dP/dtmin, total vascular conductance (TVC), renal vascular conductance (RVC), hindlimb 
vascular conductance (HVC) and conductance of all vascular beds except the hindlimbs 
(non-ischemic vascular conductance; NIVC).  dP/dtmax and dP/dtmin were calculated as 
the maximal rate of rise and fall in LVP, respectively.  Due to technical difficulties, these 
values were only calculated in four animals.  Vascular conductance for different 
vascular beds were calculated as follows: TVC = CO/MAP, RVC = RBF/MAP, HVC = 
HLBF/FAP and NIVC = (CO-HLBF)/MAP. One minute averages of all variables were 
taken during steady-state at rest, BCO at rest, mild exercise, BCO during mild exercise, 
muscle metaboreflex activation and BCO during metaboreflex activation.  Mean values 
were averaged across all animals to obtain the sample mean of the study.  The pressor 
response observed with metaboreflex activation in our experiments is a combination of 
a reflex increase in MAP due to metaboreflex activation (MAPActive) and the passive 
increase in MAP solely due to the mechanical effect of terminal aortic occluders 
(MAPPassive).  MAPPassive was calculated as COEX/(NIVCEX + HVCObserved), where the 
subscript EX indicates free-flow exercise level (6, 95).  MAPActive was calculated by 
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subtracting the passive increase in MAP from the observed MAP values at maximal 
metaboreflex activation.  HLBF during coactivation of the two reflexes was kept constant 
by increasing the occluder resistance.  We calculated the HLBF if there was no increase 
in occluder resistance (predicted HLBF) as (MAP during BCO)/(hindlimb vascular 
resistance during BCO + occluder resistance during metaboreflex activation). 
Statistical analysis 
All hemodynamic data are reported as means ± SE.  An α-level of P<0.05 was 
used to determine statistical significance.  Average responses for each animal were 
analyzed with Systat software (Systat 11.0).  Two-way ANOVA with repeated measures 
was used to compare hemodynamic data for time and/or condition effect.  In the event 
of a significant time-condition interaction, a C-matrix test for simple effects was 
performed. 
Results 
Figure 6.1 shows average hemodynamic responses evoked by BCO at rest 
before and after induction after HF.  Carotid baroreceptor unloading at rest caused a 
significant increase in MAP, CO and HR.  After induction of HF, resting MAP and CO 
were significantly lower and resting HR was significantly higher.  BCO at rest elicited 
large increases in MAP and HR in HF, however the magnitude of pressor response was 
significantly lower and HR response was markedly higher than in normal.  The small but 
significant increase in CO observed in normal was abolished in HF.  For NIVC, RVC, 
HVC, dP/dtmax and dP/dtmin, there was a significant effect of BCO and HF.  
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Figure 6.1. Average 
values for cardiovascular 
variables during rest 
(open bars) and bilateral 
carotid occlusion (BCO) at 
rest (blue bars) in normal 
(left panel) and after 
induction of heart failure 
(right panel). * p<0.05 vs. 
rest, † p<0.05 vs. normal. 
Horizontal brackets reflect 
a significant effect of BCO 
and vertical brackets 
reflect a significant effect 
of heart failure. 
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Figure 6.2. Average hemodynamic 
data during rest (open bars), mild 
exercise (Ex; grey bars) and bilateral 
carotid occlusion (BCO) during 
exercise (blue bars) in normal (left 
panel) and after induction of heart 
failure (right panel). * p<0.05 vs. 
previous setting, † p<0.05 vs. 
normal. Horizontal brackets reflect a 
significant settings effect and vertical 
brackets reflect a significant effect of 
heart failure.  
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Average cardiovascular responses to BCO during exercise before and after 
induction of HF are shown in Figure 6.2.  From rest to mild exercise, there was a 
moderate increase in CO, HR, NIVC and HVC.  BCO during mild exercise resulted in 
large increases in MAP, CO, HR and a decrease in HVC.  After induction of HF, 
responses to mild exercise were similar to those in normal animals but with attenuated 
resting and exercise levels of MAP, CO and HVC.  With BCO during exercise in HF, 
there was a significant increase in MAP and HR with no change in CO and a decrease 
in HVC.  There was a significant settings and HF effect on NIVC, RVC, dP/dtmax and 
dP/dtmin responses. 
Figure 6.3 shows the average hemodynamic changes in response to BCO during 
muscle metaboreflex activation before and after induction of HF.  Muscle metaboreflex 
activation during mild exercise elicited significant increases in MAP, CO, NIVC, dP/dtmax 
and dP/dtmin.  With BCO during metaboreflex activation, there was further large increase 
in MAP and ventricular function with significant decreases in CO and NIVC.  Statistical 
analysis showed a significant settings effect on HR, RVC and HVC in normal.  After 
induction of HF, muscle metaboreflex activation caused substantial increases in MAP 
and ventricular function but the responses are significantly attenuated compared to 
normal.  The increase in CO observed in normal animals was abolished after induction 
of HF and there was a significant vasoconstriction of non-ischemic vasculature.  BCO 
during metaboreflex activation resulted in a large pressor response, vasoconstriction of 
non-ischemic vascular beds, improvement in ventricular function, however, these 
responses were markedly lower than in normal.  There was a significant effect of HF 
and settings effect on HR, RVC and HVC responses.  
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Figure 6.3. Average hemodynamic data during rest (open bars), mild exercise (Ex; grey 
bars), muscle metaboreflex activation (MMA; red bars) and bilateral carotid occlusion 
(BCO) during MMA (purple bars) in normal (left panel) and after induction of heart 
failure (right panel). * p<0.05 vs. previous setting, † p<0.05 vs. normal. Horizontal 
brackets reflect a significant settings effect and vertical brackets reflect a significant 
effect of heart failure. 
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Figure 6.4. Absolute changes (∆) in cardiovascular responses evoked by bilateral 
carotid occlusion (BCO) during mild exercise (hatched bars), muscle metaboreflex 
activation (MMA; grey bars), sum of MMA and BCO responses during exercise (SUM; 
filled bars) and observed effect of coactivation of MMA and BCO during MMA (OBS; 
open bars). *p<0.05 vs. calculated sum of reflex-induced response during MMA and 
BCO during exercise.  
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Figure 6.4 shows average cardiovascular responses when the arterial baroreflex 
and the muscle metaboreflex were activated separately and concurrently.  To 
investigate whether the interaction between the two reflexes is altered in HF, the 
observed responses during coactivation of both reflexes in HF were compared to the 
sum of metaboreflex-induced and BCO-induced responses during exercise in HF.  In 
healthy animals, MAP, NIVC and ventricular function responses displayed an additive 
interaction, HR responses exhibited a facilitative interaction while CO and RVC 
responses demonstrate an occlusive interaction.  After induction of HF, all 
cardiovascular parameters exhibited occlusive interactions with the exception of 
ventricular function responses, which displayed an additive interaction. 
 
 
Figure 6.5. Average hindlimb blood flow (HLBF) during rest (open bars), bilateral 
carotid occlusion (BCO) during rest (blue bars), mild exercise (Ex; grey bars), BCO 
during mild exercise (blue bars), muscle metaboreflex activation (MMA; red bars) and 
BCO during MMA (purple bars). The bars inscribed with P indicate the predicted HLBF 
during coactivation of two reflexes.* p<0.05 vs. previous setting, † p<0.05 vs. normal. 
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Figure 6.5 shows HLBF responses during BCO at rest, during mild exercise and 
muscle metaboreflex activation in normal animals and in same animals after induction of 
HF.  In normal animals, there was a significant increase in HLBF with BCO at rest and 
during exercise which was abolished after induction of HF.  Although BCO during 
muscle metaboreflex activation in normal individuals caused hindlimb vasoconstriction, 
other vascular beds vasoconstricted more thereby, redirecting blood flow to ischemic 
hindlimb vasculature.  This significant increase in HLBF (predicted) during coactivation 
of the two reflexes was substantially attenuated in HF.  
Discussion 
This is the first study to investigate the effect of HF on the interaction between 
the muscle metaboreflex and the arterial baroreflex when activated concurrently.  We 
found that although baroreceptor unloading during metaboreflex activation in HF causes 
a large pressor response via peripheral vasoconstriction, the rise in MAP is significantly 
attenuated compared to normal.  Peripheral vasoconstriction occurs in all vascular beds 
including the ischemic active skeletal muscle. In normal animals, vasoconstriction in 
non-ischemic vasculature is greater than that in the ischemic muscle, partially restoring 
blood flow to the ischemic beds.  This restoration of blood flow to the ischemic muscle is 
significantly attenuated in HF.   
Muscle metaboreflex and arterial baroreflex interaction 
As previously shown, the interaction between arterial baroreflex and muscle 
metaboreflex when activated simultaneously is dependent on the hemodynamic 
parameter being investigated.  Our results agree with the previous study as MAP, NIVC 
and ventricular function responses during coactivation of two reflexes exhibit additive 
interactions, CO and RVC responses were occlusive and HR responses exhibited 
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facilitative interaction.  However, all the hemodynamic responses except ventricular 
function converted to occlusive interactions after induction of HF.  Although significantly 
attenuated in HF, dP/dtmax and dP/dtmin responses maintained an additive interaction 
upon coactivation on the two reflexes.  Therefore, the interaction between muscle 
metaboreflex and arterial baroreflex when activated simultaneously in HF is occlusive 
and the responses are significantly depressed compared to normal.  
Regulation of skeletal muscle blood flow 
Baroreceptor unloading during muscle metaboreflex activation in healthy subjects 
causes vasoconstriction in all vascular beds including the ischemic hindlimb vasculature 
but preferential vasoconstriction of the non-ischemic vasculature redistributes CO 
towards the ischemic active muscle increasing HLBF.  This increase in HLBF attenuates 
muscle metaboreflex activation.  After induction of HF, BCO during metaboreflex 
activation increases MAP via peripheral vasoconstriction, including vasoconstriction of 
the ischemic skeletal muscle.  In contrast to normal animals, there is a very small 
restoration of HLBF with coactivation of both reflexes in HF.  Smaller vasoconstriction of 
ischemic active muscle in normal animals could be a result of functional sympatholysis; 
attenuated sympathetic vasoconstriction of active muscle due to metabolic 
accumulation in the muscle (63).  Since functional sympatholysis is impaired in HF (85), 
the unopposed sympathetic vasoconstriction in the ischemic vascular bed prevents any 
significant increase in HLBF in HF.  
Perspectives and significance 
In normal individuals, the arterial baroreflex buffers about one-half of the 
metaboreflex-induced pressor response by attenuating peripheral vasoconstriction (40).  
In heart failure, mechanisms of muscle metaboreflex activation switch from CO-
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mediated to peripheral vasoconstriction-mediated pressor response (29, 51, 81).  
Impaired baroreflex buffering of the metaboreflex in HF would markedly increase 
sympathetic vasoconstriction of all vascular beds, especially to the active ischemic 
muscle. 
  
89 
 
APPENDIX A 
IACUC Protocol Approval Letter 
 
 
 
90 
 
APPENDIX B 
Copyright License Agreement for Chapter 2 
 
  
91 
 
APPENDIX C 
Copyright License Agreement for Chapter 3 
 
  
92 
 
REFERENCES 
1.  Alam M and Smirk FH. Observations in man upon a blood pressure raising reflex 
arising from the voluntary muscles. J Physiol 89: 372-383, 1937. 
2.  Amann M, Blain GM, Proctor LT, Sebranek JJ, Pegelow DF and Dempsey JA. 
Group III and IV muscle afferents contribute to ventilatory and cardiovascular 
response to rhythmic exercise in humans. J Appl Physiol 109: 966-976, 2010. 
3.  Ansorge EJ, Shah SH, Augustyniak R, Rossi NF, Collins HL and O'Leary DS. 
Muscle metaboreflex control of coronary blood flow. Am J Physiol Heart Circ 
Physiol 283: H526-H532, 2002. 
4.  Asmussen E and Nielsen M. Experiments on nervous factors controlling 
respiration and circulation during exercise employing blocking of the blood flow. 
Acta Physiol Scand 60: 103-111, 1964. 
5.  Augustyniak RA, Ansorge EJ and O'Leary DS. Muscle metaboreflex control of 
cardiac output and peripheral vasoconstriction exhibit differential latencies. Am J 
Physiol 278: H530-H537, 2000. 
6.  Augustyniak RA, Collins HL, Ansorge EJ, Rossi NF and O'Leary DS. Severe 
exercise alters the strength and mechanisms of the muscle metaboreflex. Am J 
Physiol Heart Circ Physiol 280: H1645-H1652, 2001. 
7.  Barrett-O'Keefe Z, Ives SJ, Trinity JD, Morgan G, Rossman MJ, Donato AJ, 
Runnels S, Morgan DE, Gmelch BS, Bledsoe AD, Richardson RS and Wray DW. 
Taming the "sleeping giant": the role of endothelin-1 in the regulation of skeletal 
muscle blood flow and arterial blood pressure during exercise. Am J Physiol 
Heart Circ Physiol 304: H162-H169, 2013. 
8.  Berecek KH and Brody MJ. Evidence for a neurotransmitter role for epinephrine 
93 
 
derived from the adrenal medulla. Am J Physiol 242: H593-H601, 1982. 
9.  Boushel R, Madsen P, Nielsen HB, Quistorff B and Secher NH. Contribution of 
pH, diprotonated phosphate and potassium for the reflex increase in blood 
pressure during handgrip. Acta Physiol Scand 164: 269-275, 1998. 
10.  Buckwalter JB, Hamann JJ and Clifford PS. Neuropeptide Y1 receptor 
vasoconstriction in exercising canine skeletal muscles. J Appl Physiol (1985 ) 99: 
2115-2120, 2005. 
11.  Collins HL, Augustyniak RA, Ansorge EJ and O'Leary DS. Carotid baroreflex 
pressor responses at rest and during exercise:cardiac output vs. regional 
vasoconstriction. Am J Physiol Heart Circ Physiol 280: H642-H648, 2001. 
12.  Collins HL and Dicarlo SE. Cardiac afferents attenuate the muscle metaboreflex 
in the rat. J Appl Physiol 75: 114-120, 1993. 
13.  Coutsos M, Sala-Mercado JA, Ichinose M, Li Z, Dawe EJ and O'Leary DS. 
Muscle metaboreflex-induced coronary vasoconstriction functionally limits 
increases in ventricular contractility. J Appl Physiol 109: 271-278, 2010. 
14.  Coutsos M, Sala-Mercado JA, Ichinose M, Li Z, Dawe EJ and O'Leary DS. 
Muscle metaboreflex-induced coronary vasoconstriction limits ventricular 
contractility during dynamic exercise in heart failure. Am J Physiol Heart Circ 
Physiol 304: H1029-H1037, 2013. 
15.  Coutsos M, Sala-Mercado JA, Ichinose M, Li Z and O'Leary DS. Muscle 
Metaboreflex Control of Coronary Blood Flow and Ventricular Contractility During 
Dynamic Exercise in Heart Failure. FASEB J 2009. 
16.  Crisafulli A, Salis E, Tocco F, Melis F, Milia R, Pittau G, Caria MA, Solinas R, 
Meloni L, Pagliaro P and Concu A. Impaired central hemodynamic response and 
94 
 
exaggerated vasoconstriction during muscle metaboreflex activation in heart 
failure patients. Am J Physiol Heart Circ Physiol 292: H2988-H2996, 2007. 
17.  Crisafulli A, Scott AC, Wensel R, Davos CH, Francis DP, Pagliaro P, Coats AJS, 
Concu A and Piepoli MF. Muscle metaboreflex-induced increases in stroke 
volume. Medicine and Science in Sports and Exercise 35: 221-228, 2003. 
18.  Crisafulli A, Piras F, Filippi M, Piredda C, Chiappori P, Melis F, Milia R, Tocco F 
and Concu A. Role of heart rate and stroke volume during muscle metaboreflex-
induced cardiac output increase: differences between activation during and after 
exercise. The Journal of Physiological Sciences 61: 385-394, 2011. 
19.  Delorey DS, Hamann JJ, Valic Z, Kluess HA, Clifford PS and Buckwalter JB. 
Alpha-Adrenergic receptor responsiveness is preserved during prolonged 
exercise. Am J Physiol Heart Circ Physiol 292: H392-H398, 2007. 
20.  Dicarlo SE and Bishop VS. Onset of exercise shifts operating point of arterial 
baroreflex to higher pressures. Am J Physiol 262: H303-H307, 1992. 
21.  Dicarlo SE, Chen CY and Collins HL. Onset of exercise increases lumbar 
sympathetic nerve activity in rats. Med Sci Sports Exerc 28: 677-684, 1996. 
22.  Drexler H, Hayoz D, Munzel T, Hornig B, Just H, Brunner HR and Zelis R. 
Endothelial function in chronic congestive heart failure. Am J Cardiol 69: 1596-
1601, 1992. 
23.  Drexler H, Riede U, Munzel T, Konig H, Funke E and Just H. Alterations of 
skeletal muscle in chronic heart failure. Circulation 85: 1751-1759, 1992. 
24.  Eiken O and Bjurstedt H. Dynamic exercise in man as influenced by experimental 
restriction of blood flow in the working muscles. Acta Physiol Scand 131: 339-
345, 1987. 
95 
 
25.  Elfellah MS, Dalling R, Kantola IM and Reid JL. Beta-adrenoceptors and human 
skeletal muscle characterisation of receptor subtype and effect of age. Br J Clin 
Pharmacol 27: 31-38, 1989. 
26.  Fisher JP, Seifert T, Hartwich D, Young CN, Secher NH and Fadel PJ. 
Autonomic control of heart rate by metabolically sensitive skeletal muscle 
afferents in humans. J Physiol 588: 1117-1127, 2010. 
27.  Hales JR, Rowell LB and King RB. Regional distribution of blood flow in awake 
heat-stressed baboons. Am J Physiol 237: H705-H712, 1979. 
28.  Hales JRS and Dampney RAL. The redistribution of cardiac output in the dog 
during heat stress. J Thermal Biol 1: 29-34, 1975. 
29.  Hammond RL, Augustyniak RA, Rossi NF, Churchill PC, Lapanowski K and 
O'Leary DS. Heart failure alters the strength and mechanisms of the muscle 
metaboreflex. Am J Physiol 278: H818-H828, 2000. 
30.  Hammond RL, Augustyniak RA, Rossi NF, Lapanowski K, Dunbar JC and 
O'Leary DS. Alteration of humoral and peripheral vascular responses during 
graded exercise in heart failure. J Appl Physiol 90: 55-61, 2001. 
31.  Hjemdahl P, Belfrage E and Daleskog M. Vascular and metabolic effects of 
circulating epinephrine and norepinephrine. Concentration-effect study in dogs. J 
Clin Invest 64: 1221-1228, 1979. 
32.  Ichinose MJ, Sala-Mercado JA, Coutsos M, Li Z, Ichinose TK, Dawe E and 
O'Leary DS. Modulation of cardiac output alters the mechanisms of the muscle 
metaboreflex pressor response. Am J Physiol Heart Circ Physiol 298: H245-
H250, 2010. 
33.  Joyner MJ. Does the pressor response to ischemic exercise improve blood flow 
96 
 
to contracting muscles in humans? J Appl Physiol 71: 1496-1501, 1991. 
34.  Kaufman MP and Rybicki KJ. Discharge properties of group III and IV muscle 
afferents: their responses to mechanical and metabolic stimuli. Circ Res 61: I60-
I65, 1987. 
35.  Kaufman MP, Rybicki KJ, Waldrop TG and Ordway GA. Effect of ischemia on 
responses of group III and IV afferents to contraction. J Appl Physiol 57: 644-
650, 1984. 
36.  Kaur J, Machado TM, Alvarez A, Krishnan AC, Hanna HW, Altamimi YH, 
Senador D, Spranger MD and O'Leary DS. Muscle metaboreflex activation during 
dynamic exercise vasoconstricts ischemic active skeletal muscle. Am J Physiol 
Heart Circ Physiol 309: H2145-H2151, 2015. 
37.  Kaur J, Spranger MD, Hammond RL, Krishnan AC, Alvarez A, Augustyniak RA 
and O'Leary DS. Muscle metaboreflex activation during dynamic exercise evokes 
epinephrine release resulting in beta2-mediated vasodilation. Am J Physiol Heart 
Circ Physiol 308: H524-H529, 2015. 
38.  Kim JK, Augustyniak RA, Sala-Mercado JA, Hammond RL, Ansorge EJ and 
O'Leary DS. Heart failure alters the strength and mechanisms of arterial 
baroreflex pressor responses during dynamic exercise. Am J Physiol Heart Circ 
Physiol 287: H1682-H1688, 2004. 
39.  Kim JK, Sala-Mercado JA, Hammond RL, Rodriguez J, Scislo TJ and O'Leary 
DS. Attenuated arterial baroreflex buffering of muscle metaboreflex in heart 
failure. Am J Physiol Heart Circ Physiol 289: H2416-H2423, 2005. 
40.  Kim JK, Sala-Mercado JA, Rodriguez J, Scislo TJ and O'Leary DS. Arterial 
baroreflex alters strength and mechanisms of muscle metaboreflex during 
97 
 
dynamic exercise. Am J Physiol Heart Circ Physiol 288: H1374-H1380, 2005. 
41.  Kitchen AM, Scislo TJ and O'Leary DS. NTS purinoceptor activation elicits 
hindlimb vasodilation primarily via a beta-adrenergic mechanism. Am J Physiol 
278: H1775-H1782, 2000. 
42.  Lynch GS and Ryall JG. Role of beta-adrenoceptor signaling in skeletal muscle: 
implications for muscle wasting and disease. Physiol Rev 88: 729-767, 2008. 
43.  McCloskey DL and Mitchell JH. Reflex cardiovascular and respiratory responses 
originating exercising muscle. J Physiol 224: 173-186, 1972. 
44.  McClure JM, O'Leary DS and Scislo TJ. Stimulation of NTS A1 adenosine 
receptors evokes counteracting effects on hindlimb vasculature. Am J Physiol 
Heart Circ Physiol 289: H2536-H2542, 2005. 
45.  McClure JM, O'Leary DS and Scislo TJ. Stimulation of NTS A1 adenosine 
receptors evokes counteracting effects on hindlimb vasculature 2. Am J Physiol 
Heart Circ Physiol 289: H2536-H2542, 2005. 
46.  McClure JM, O'Leary DS and Scislo TJ. Neural and humoral control of regional 
vascular beds via A1 adenosine receptors located in the nucleus tractus solitarii. 
Am J Physiol Regul Integr Comp Physiol 2010. 
47.  Minneman KP, Hedberg A and Molinoff PB. Comparison of beta adrenergic 
receptor subtypes in mammalian tissues. J Pharmacol Exp Ther 211: 502-508, 
1979. 
48.  Mittelstadt SW, Bell LB, O'Hagan KP and Clifford PS. Muscle chemoreflex alters 
vascular conductance in nonischemic exercising skeletal muscle. J Appl Physiol 
77: 2761-2766, 1994. 
49.  Mittelstadt SW, Bell LB, O'Hagan KP, Sulentic JE and Clifford PS. Muscle 
98 
 
chemoreflex causes renal vascular constriction. Am J Physiol 270: H951-H956, 
1996. 
50.  Musch TI, Friedman DB, Pitetti KH, Haidet GC, Stray-Gundersen J, Mitchell JH 
and Ordway GA. Regional distribution of blood flow of dogs during graded 
dynamic exercise. J Appl Physiol 63: 2269-2277, 1987. 
51.  Notarius CF, Atchison DJ and Floras JS. Impact of heart failure and exercise 
capacity on sympathetic response to handgrip exercise. American Journal of 
Physiology-Heart and Circulatory Physiology 280: H969-H976, 2001. 
52.  O'Leary DS. Regional vascular resistance vs. conductance: which index for 
baroreflex responses? Am J Physiol 260: H632-H637, 1991. 
53.  O'Leary DS. Heart rate control during exercise by baroreceptors and skeletal 
muscle afferents. Med Sci Sports Exerc 28: 210-217, 1996. 
54.  O'Leary DS. Point: the muscle metaboreflex does restore blood flow to 
contracting muscles. J Appl Physiol 100: 357-358, 2006. 
55.  O'Leary DS and Augustyniak RA. Muscle metaboreflex increases ventricular 
performance in conscious dogs. Am J Physiol 275: H220-H224, 1998. 
56.  O'Leary DS, Augustyniak RA, Ansorge EJ and Collins HL. Muscle metaboreflex 
improves O2 delivery to ischemic active skeletal muscle. Am J Physiol 276: 
H1399-H1403, 1999. 
57.  O'Leary DS, Rossi NF and Churchill PC. Muscle metaboreflex control of 
vasopressin and renin release. Am J Physiol 264: H1422-H1427, 1993. 
58.  O'Leary DS, Sala-Mercado JA, Augustyniak RA, Hammond RL, Rossi NF and 
Ansorge EJ. Impaired muscle metaboreflex-induced increases in ventricular 
function in heart failure. Am J Physiol Heart Circ Physiol 287: H2612-H2618, 
99 
 
2004. 
59.  O'Leary DS and Sheriff DD. Is the muscle metaboreflex important in control of 
blood flow to ischemic active skeletal muscle in dogs? Am J Physiol 268: H980-
H986, 1995. 
60.  Ogoh S, Fadel PJ, Nissen P, Jans O, Selmer C, Secher NH and Raven PB. 
Baroreflex-mediated changes in cardiac output and vascular conductance in 
response to alterations in carotid sinus pressure during exercise in humans. 
Journal of Physiology-London 550: 317-324, 2003. 
61.  Olivier NB and Stephenson RB. Characterization of baroreflex impairment in 
conscious dogs with pacing-induced heart failure. Am J Physiol 265: R1132-
R1140, 1993. 
62.  Potts JT and Mitchell JH. Rapid resetting of carotid baroreceptor reflex by 
afferent input from skeletal muscle receptors. American Journal of Physiology-
Heart and Circulatory Physiology 44: H2000-H2008, 1998. 
63.  Remensnyder JP, Mitchell JH and Sarnoff SJ. Functional sympatholysis during 
muscular activity. Observations on influence of carotid sinus on oxygen uptake. 
Circ Res 11: 370-380, 1962. 
64.  Rodman JR, Henderson KS, Smith CA and Dempsey JA. Cardiovascular effects 
of the respiratory muscle metaboreflexes in dogs: rest and exercise. J Appl 
Physiol 95: 1159-1169, 2003. 
65.  Rotto DM and Kaufman MP. Effect of metabolic products of muscular contraction 
on discharge of group III and IV afferents. J Appl Physiol 64: 2306-2313, 1988. 
66.  Rowell LB, Hermansen L and Blackmon JR. Human cardiovascular and 
respiratory responses to graded muscle ischemia. J Appl Physiol 41: 693-701, 
100 
 
1976. 
67.  Rowell LB and O'Leary DS. Reflex control of the circulation during exercise: 
chemoreflexes and mechanoreflexes. J Appl Physiol 69: 407-418, 1990. 
68.  Rowell LB, Savage MV, Chambers J and Blackmon JR. Cardiovascular 
responses to graded reductions in leg perfusion in exercising humans. Am J 
Physiol 261: H1545-H1553, 1991. 
69.  Sala-Mercado JA, Spranger MD, Abu-Hamdah R, Kaur J, Coutsos M, Stayer D, 
Augustyniak RA and O'Leary DS. Attenuated muscle metaboreflex-induced 
increases in cardiac function in hypertension. Am J Physiol Heart Circ Physiol 
305: H1548-H1554, 2013. 
70.  Sala-Mercado JA, Hammond RL, Kim JK, Rossi NF, Stephenson LW and 
O'Leary DS. Muscle metaboreflex control of ventricular contractility during 
dynamic exercise. Am J Physiol Heart Circ Physiol 290: H751-H757, 2006. 
71.  Sheriff DD, Augustyniak RA and O'Leary DS. Muscle chemoreflex-induced 
increases in right atrial pressure. Am J Physiol 275: H767-H775, 1998. 
72.  Sheriff DD, O'Leary DS, Scher AM and Rowell LB. Baroreflex attenuates pressor 
response to graded muscle ischemia in exercising dogs. Am J Physiol 258: 
H305-H310, 1990. 
73.  Sheriff DD, Wyss CR, Rowell LB and Scher AM. Does inadequate oxygen 
delivery trigger pressor response to muscle hypoperfusion during exercise? Am J 
Physiol 253: H1199-H1207, 1987. 
74.  Shoemaker JK, Mattar L, Kerbeci P, Trotter S, Arbeille P and Hughson RL. WISE 
2005: stroke volume changes contribute to the pressor response during ischemic 
handgrip exercise in women. J Appl Physiol 103: 228-233, 2007. 
101 
 
75.  Sinoway LI, Rea RF, Mosher TJ, Smith MB and Mark AL. Hydrogen ion 
concentration is not the sole determinant of muscle metaboreceptor responses in 
humans. J Clin Invest 89: 1875-1884, 1992. 
76.  Sinoway LI, Smith MB, Enders B, Leuenberger U, Dzwonczyk T, Gray K, Whisler 
S and Moore RL. Role of diprotonated phosphate in evoking muscle reflex 
responses in cats and humans. Am J Physiol 267: H770-H778, 1994. 
77.  Sinoway LI, Wroblewski KJ, Prophet SA, Ettinger SM, Gray KS, Whisler SK, 
Miller G and Moore RL. Glycogen depletion-induced lactate reductions attenuate 
reflex responses in exercising humans. Am J Physiol 263: H1499-H1505, 1992. 
78.  Spranger MD, Sala-Mercado JA, Coutsos M, Kaur J, Stayer D, Augustyniak RA 
and O'Leary DS. Role of cardiac output versus peripheral vasoconstriction in 
mediating muscle metaboreflex pressor responses: dynamic exercise versus 
postexercise muscle ischemia. Am J Physiol Regul Integr Comp Physiol 304: 
R657-R663, 2013. 
79.  Stephenson RB and Donald DE. Reflexes from isolated carotid sinuses of intact 
and vagotomized conscious dogs. Am J Physiol 238: H815-H822, 1980. 
80.  Stephenson RB and Donald DE. Reversible vascular isolation of carotid sinuses 
in conscious dogs. Am J Physiol 238: H809-H814, 1980. 
81.  Sterns DA, Ettinger SM, Gray KS, Whisler SK, Mosher TJ, Smith MB and 
Sinoway LI. Skeletal muscle metaboreceptor exercise responses are attenuated 
in heart failure. Circulation 84: 2034-2039, 1991. 
82.  Sullivan MJ, Green HJ and Cobb FR. Skeletal muscle biochemistry and histology 
in ambulatory patients with long-term heart failure. Circulation 81: 518-527, 1990. 
83.  Sun SY, Wang W, Zucker IH and Schultz HD. Enhanced peripheral chemoreflex 
102 
 
function in conscious rabbits with pacing-induced heart failure. J Appl Physiol 
(1985 ) 86: 1264-1272, 1999. 
84.  Thomas GD and Segal SS. Neural control of muscle blood flow during exercise. 
J Appl Physiol (1985 ) 97: 731-738, 2004. 
85.  Thomas GD, Zhang W and Victor RG. Impaired modulation of sympathetic 
vasoconstriction in contracting skeletal muscle of rats with chronic myocardial 
infarctions: role of oxidative stress. Circ Res 88: 816-823, 2001. 
86.  Vanhoutte B. Heterogeneity in vascular smooth muscle. In: Microcirculation, 
edited by Kaley G and Altura BM.  Baltimore: University Park Press, 1978, p. 
181-310. 
87.  Victor RG, Bertocci LA, Pryor SL and Nunnally RL. Sympathetic nerve discharge 
is coupled to muscle cell pH during exercise in humans. J Clin Invest 82: 1301-
1305, 1988. 
88.  Victor RG and Seals DR. Reflex stimulation of sympathetic outflow during 
rhythmic exercise in humans. Am J Physiol 257: H2017-H2024, 1989. 
89.  Victor RG, Seals DR and Mark AL. Differential control of heart rate and 
sympathetic nerve activity during dynamic exercise. Insight from intraneural 
recordings in humans. J Clin Invest 79: 508-516, 1987. 
90.  Vongpatanasin W, Wang Z, Arbique D, Arbique G, Adams-Huet B, Mitchell JH, 
Victor RG and Thomas GD. Functional sympatholysis is impaired in hypertensive 
humans. J Physiol 589: 1209-1220, 2011. 
91.  Walgenbach SC and Donald DE. Inhibition by carotid baroreflex of exercise-
induced increases in arterial pressure. Circ Res 52: 253-262, 1983. 
92.  Wang HJ, Wang W, Cornish KG, Rozanski GJ and Zucker IH. Cardiac 
103 
 
sympathetic afferent denervation attenuates cardiac remodeling and improves 
cardiovascular dysfunction in rats with heart failure. Hypertension 64: 745-755, 
2014. 
93.  Wang W, Chen JS and Zucker IH. Carotid sinus baroreceptor sensitivity in 
experimental heart failure. Circulation 81: 1959-1966, 1990. 
94. Wilson JR, Lanoce V, Frey MJ and Ferraro N. Arterial baroreceptor control of 
peripheral vascular resistance in experimental heart failure. Am Heart J 119: 
1122-1130, 1990. 
95. Wyss CR, Ardell JL, Scher AM and Rowell LB. Cardiovascular responses to 
graded reductions in hindlimb perfusion in exercising dogs. Am J Physiol 245: 
H481-H486, 1983. 
 
 
  
104 
 
ABSTRACT 
MUSCLE METABOREFLEX AND ARTERIAL BAROREFLEX: ACTION, 
INTERACTION AND ALTERED CONTROL IN HEART FAILURE 
by 
JASDEEP KAUR 
May 2016 
Advisor:  Dr. Donal S. O’Leary 
Major:  Physiology 
Degree:  Doctor of Philosophy  
Stimulation of skeletal muscle afferents by metabolites that accumulate in the 
exercising muscle elicits a large pressor response, termed the muscle metaboreflex.  
Muscle metaboreflex activation during submaximal exercise induces large increases in 
arterial pressure, cardiac output, heart rate and ventricular contractility however, the 
vascular responses have varied in previous studies.  We addressed three specific 
questions: 1) what are the mechanism(s) regulating the non-ischemic vasculature 
during muscle metaboreflex activation in normal subjects, 2) whether muscle 
metaboreflex activation vasoconstricts the ischemic active muscle from which this reflex 
originates and if this vasoconstriction is exaggerated in heart failure and 3) how do the 
arterial baroreflex and muscle metaboreflex interact with each other when activated 
simultaneously in normal and heart failure animals.  Using chronically instrumented 
canine model, data was collected before and after the induction of heart failure.  We 
found that: 1) muscle metaboreflex activation induces epinephrine release causing β2-
mediated vasodilation in skeletal muscle, 2) muscle metaboreflex activation elicits 
vasoconstriction of ischemic active muscle which is exaggerated after induction of heart 
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failure and 3) interaction between baroreflex and muscle metaboreflex in normal 
animals depends on the parameter being investigated; however in heart failure, most 
cardiovascular variables exhibit occlusive interactions.  Preferential vasoconstriction of 
non-ischemic vasculature redirects cardiac output and increases hindlimb blood flow in 
normal animals but this increase is significantly attenuated in heart failure.  The 
exaggerated vasoconstriction and limited increase in blood flow to the ischemic muscle 
would impair the ability to exercise and contribute to exercise intolerance in heart failure 
patients.  
  
106 
 
AUTOBIOGRAPHICAL STATEMENT 
JASDEEP KAUR 
Education 
2012–2016 Ph.D., Physiology  
Wayne State University School of Medicine, Detroit, MI 
2008–2012 B.S. Biological Sciences, summa cum laude  
Wayne State University, Detroit, MI  
Publications 
1. Kaur J, Machado TM, Alvarez A, Krishnan AC, Hanna HW, Altamimi YH, Senador D, 
Spranger MD, O'Leary DS. Muscle metaboreflex activation during dynamic exercise 
vasoconstricts the ischemic active skeletal muscle. Am J Physiol Heart Circ Physiol 309(12): 
H2145-51, 2015.  
2. Spranger MD, Kaur J, Sala-Mercado JA, Machado TM, Krishnan AC, Alvarez A, O'Leary DS. 
Attenuated muscle metaboreflex-induced pressor response during post-exercise muscle 
ischemia in renovascular hypertension. Am J Physiol Reg Integ Comp Physiol 308 (7): R650-
R658, 2015.  
3. Kaur J, Spranger MD, Hammond RL, Krishnan AC, Alvarez A, Augustyniak RA and O'Leary 
DS. Muscle metaboreflex activation during dynamic exercise evokes epinephrine release 
resulting in β2-mediated vasodilation. Am J Physiol Heart Circ Physiol 308 (5): H524-H529, 
2015. 
4. Spranger MD, Sala-Mercado JA, Coutsos M, Kaur J, Stayer D, Augustyniak RA and O'Leary 
DS. Role of cardiac output versus peripheral vasoconstriction in mediating muscle 
metaboreflex pressor responses: dynamic exercise versus post-exercise muscle ischemia. 
Am J Physiol Reg Integ Comp Physiol 304(8): R657-63, 2013.  
5. Sala-Mercado JA, Spranger MD, Abu-Hamdah R, Kaur J, Coutsos M, Stayer D,Augustyniak 
RA and O'Leary DS. Attenuated muscle metaboreflex-induced increases in cardiac function 
in hypertension. Am J Physiol Heart Circ Physiol 305: H1548–H1554, 2013. 
Abstracts 
1. Kaur J, Spranger MD, Machado TM, Krishnan AC, Alvarez A and O’Leary DS. Baroreflex 
sympatho-activation during muscle metaboreflex activation improves blood flow to the 
ischemic muscle. FASEB J 29: 648.8, 2015.  
2. Kaur J, Spranger MD, Machado TM, Krishnan AC, Alvarez A, Hanna HW, Altamimi YH and 
O’Leary DS. Muscle metaboreflex-induced vasoconstriction of ischemic active skeletal 
muscle. FASEB J 29: 1054.1, 2015. 
3. Kaur J, Spranger MD, Hammond RL, Krishnan AC, Alvarez A, Augustyniak RA and O’Leary 
DS. Muscle metaboreflex activation during dynamic exercise evokes epinephrine release 
resulting in β2-mediated vasodilation. FASEB J 28:1172.2, 2014. 
4. Spranger MD, Kaur J, Sala-Mercado JA, Krishnan AC, Alvarez A and O’Leary DS. 
Mechanisms mediating the muscle metaboreflex pressor response during post-exercise 
muscle ischemia are altered in hypertension. FASEB J 28:1170.2, 2014. 
5. Augustyniak RA, Spranger MD, Abu-Hamdah R, Kaur J, Hammond RL, Sala-Mercado JA, 
Ichinose M and O’Leary DS. Hypertension impairs spontaneous baroreflex heart rate control 
during exercise and muscle metaboreflex activation. FASEB J 28:1132.9, 2014. 
6. Spranger MD, Sala-Mercado JA, Kaur J, Abu-Hamdah R, Augustyniak RA and O’Leary DS. 
Muscle metaboreflex-induced increases in ventricular performance are limited in 
hypertension due to exaggerated coronary vasoconstriction. FASEB J 27:1118.16, 2013. 
